Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria 51000000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favourable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 30.1 60.0 34.7 30.3 45.8 22.4 33.9 52.6 65.0 27.0 52.1 20.5 39.3 55.6 25.2 30.5 44.4 30.0 27.9 196.2 31.4 36.1 94.0 64.8 25.2 40.2 42.3 31.8 28.6 49.0 73.2 35.9 25.7 41.5 28.3 54.9 37.6 42.6 42.8 182.2 34.0 50.4 36.6 22.6 32.1 46.7 24.0 19.9 45.6 35.1 99.7 41.1 31.5 26.4 58.7 110.9 17.9 64.5 44.2 63.6 124.8 42.5 43.4 57.8 54.2 70.4 78.2 64.1 49.3 69.9 76.0 66.7 64.9 33.7 100.9 30.3 59.7 79.4 99.5 75.7 71.0 44.9 55.9 66.7 56.0 80.4 46.1 141.1 63.4 72.1 53.2 54.8 57.1 78.3 53.8 59.7 64.9 44.3 72.5 69.4 54.1 45.8 71.8 67.2 136.5 103.0 104.2 58.8 54.9 36.1 45.2 60.5 58.2 82.4 45.5 41.9 36.2 21.9 42.9 68.6 58.7 65.0 41.7 84.9 44.5 11.8 64.5 17.9 43.5 58.2 55.8 58.7 52.4 47.5 110.9 44.0 63.6 52.8 6.7 44.2 52.2 54.0 58.9 124.8 34.7 45.8 52.6 65.0 31.4 36.1 42.3 31.8 41.5 19.9 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56646068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria 100000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavourable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favourable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 41.3 66.2 32.4 34.1 53.4 39.3 33.1 55.4 92.6 26.1 73.0 34.4 36.1 68.1 27.9 28.5 58.6 28.5 36.9 225.0 33.2 34.9 95.2 85.7 28.3 39.2 40.5 35.5 25.1 42.7 85.2 30.1 31.3 69.6 29.0 78.5 42.8 64.7 38.1 236.2 42.3 74.6 35.5 24.9 33.5 51.0 31.4 18.3 47.5 38.4 123.6 45.8 36.6 32.8 41.2 91.7 40.2 90.1 36.3 46.6 105.6 65.7 80.0 63.6 98.1 57.4 61.4 112.4 66.9 62.5 115.7 65.9 129.9 73.4 117.0 72.5 82.4 88.2 134.0 81.1 104.8 54.8 92.8 128.3 74.7 79.6 71.1 143.5 90.9 75.2 81.9 90.4 116.8 95.0 115.5 134.9 97.0 61.0 106.3 84.4 107.0 154.1 102.4 71.2 149.1 126.0 117.2 72.8 64.7 102.2 146.4 113.7 137.4 108.5 64.4 45.6 50.8 66.5 72.2 65.1 80.9 121.0 68.6 96.0 69.8 40.2 64.6 34.6 40.2 80.6 44.9 41.2 38.0 42.7 91.7 31.7 31.1 36.7 17.8 36.3 90.1 46.3 46.6 105.6 32.4 53.4 55.4 92.6 33.2 34.9 40.5 35.5 69.6 18.3 ATP5F1C "ATP5C, ATP5C1, ATP5CL1" ENSG00000165629 "ATP synthase F1 subunit gamma" P36542 10 7788129-7807815 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060949 Approved 2600000 "HPA060949: " "unprognostic (1.81e-2)" "unprognostic (8.34e-2)" "unprognostic (3.87e-2)" "unprognostic (1.69e-2)" "unprognostic (2.17e-2)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (8.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.31e-3)" "unprognostic (1.62e-1)" "unprognostic (4.12e-1)" "prognostic favourable (9.26e-4)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-2)" "unprognostic (4.08e-2)" 35.3 75.5 30.9 24.4 33.5 23.1 31.4 27.8 38.7 26.1 48.5 20.3 25.7 45.3 27.6 30.4 48.2 22.2 30.5 138.0 29.5 28.5 98.2 70.9 21.6 21.4 30.3 28.1 22.9 46.9 43.3 23.3 38.8 43.6 26.7 52.1 26.9 46.2 29.2 98.1 24.9 64.5 33.6 23.2 30.4 38.1 18.0 18.7 45.8 35.7 97.9 34.1 39.7 23.1 42.0 75.7 57.5 75.5 41.0 51.3 59.2 44.1 40.5 40.6 33.9 36.9 49.0 38.0 31.9 29.4 59.8 58.8 79.9 43.7 49.0 24.5 40.6 49.9 47.9 52.8 52.7 33.3 58.9 52.4 27.8 70.0 28.5 28.3 38.3 38.8 37.1 36.1 19.7 70.0 41.3 34.6 58.6 65.2 66.7 32.7 26.1 32.8 43.4 30.5 67.0 101.4 43.8 21.8 26.6 29.2 62.8 56.5 67.1 46.8 33.5 25.3 31.9 54.7 33.9 23.0 28.6 39.8 36.5 42.8 20.3 57.5 55.4 46.0 33.6 71.9 38.5 42.0 38.2 36.2 75.7 32.1 31.8 34.6 17.7 41.0 75.5 50.8 51.3 59.2 30.9 33.5 27.8 38.7 29.5 28.5 30.3 28.1 43.6 18.7 ATP5F1D ATP5D ENSG00000099624 "ATP synthase F1 subunit delta" P30049 19 1241746-1244826 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 337.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002865 Approved 4200000 "HPA002865: AB_1078244" "unprognostic (4.80e-2)" "unprognostic (9.34e-2)" "unprognostic (7.77e-2)" "prognostic favourable (1.23e-4)" "unprognostic (1.64e-2)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (6.75e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-1)" "prognostic favourable (4.60e-4)" "unprognostic (6.95e-2)" "prognostic favourable (3.46e-5)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" 30.4 25.7 27.4 13.7 30.1 19.5 19.8 22.6 51.7 14.4 36.7 16.7 16.0 42.7 14.3 14.9 23.9 15.3 18.1 59.3 25.9 20.6 33.3 51.8 12.2 33.4 25.6 24.1 15.2 46.5 15.5 18.4 12.4 28.5 17.6 14.1 17.9 48.1 23.1 337.3 24.3 33.2 21.1 14.5 19.2 33.4 10.2 9.8 21.5 23.0 60.6 22.9 17.6 14.5 67.7 78.2 33.9 64.6 52.8 64.3 50.8 24.2 13.3 4.1 15.5 4.8 7.2 15.6 16.7 7.1 9.9 7.3 13.9 6.5 24.7 10.8 5.8 20.9 4.6 17.3 1.3 17.0 45.2 14.9 16.4 18.1 12.1 26.0 22.2 14.2 4.8 4.0 5.5 10.5 21.6 19.8 4.5 36.9 28.2 18.8 18.1 65.7 27.0 11.0 51.3 16.5 16.0 16.6 19.1 11.1 17.7 27.5 13.2 12.4 15.1 9.1 12.4 21.7 13.8 50.6 25.5 9.2 16.7 12.3 13.6 33.9 64.6 27.1 50.7 61.3 61.1 64.8 64.3 55.7 72.1 67.7 59.9 54.9 22.5 52.8 49.0 78.2 62.0 50.8 27.4 30.1 22.6 51.7 25.9 20.6 25.6 24.1 28.5 9.8 ATP5F1E ATP5E ENSG00000124172 "ATP synthase F1 subunit epsilon" P56381 20 59025467-59032382 "Disease related genes, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.73e-1)" "unprognostic (6.30e-2)" "unprognostic (8.16e-2)" "unprognostic (9.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.92e-3)" "unprognostic (7.88e-3)" "unprognostic (2.51e-1)" "unprognostic (5.01e-2)" "unprognostic (6.41e-2)" "unprognostic (4.35e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (2.82e-4)" "unprognostic (3.98e-1)" "unprognostic (3.21e-1)" "unprognostic (1.67e-1)" "unprognostic (2.44e-2)" 47.2 58.1 41.9 58.8 44.2 65.7 55.2 26.9 43.7 19.4 40.2 15.6 29.5 50.5 22.1 29.4 29.8 16.6 29.6 93.2 33.0 33.1 43.6 42.2 41.0 56.9 42.8 26.5 17.8 44.1 13.0 44.0 22.3 40.0 22.4 21.8 16.6 32.9 25.6 133.3 15.7 48.5 40.4 42.8 41.8 42.4 23.5 21.4 26.7 29.7 60.3 24.9 22.3 28.6 48.8 85.9 103.7 63.8 32.6 54.2 88.6 28.2 9.2 19.3 17.6 18.3 17.2 12.9 30.2 11.3 19.8 12.8 28.9 28.0 15.4 36.9 15.0 27.4 13.2 23.0 13.2 12.6 14.2 51.6 21.0 24.9 16.7 36.2 46.6 18.2 20.3 11.9 14.9 14.6 19.2 22.4 11.3 26.2 46.1 56.5 6.5 38.3 22.7 27.3 29.5 20.1 15.5 19.4 29.2 50.7 53.8 58.6 35.8 59.7 51.1 41.7 44.0 27.4 40.6 35.8 45.5 45.6 40.3 22.7 22.8 66.1 59.6 102.8 36.0 63.8 34.2 48.8 44.1 40.4 50.6 41.4 35.6 39.7 103.7 32.6 62.8 85.9 54.2 88.6 41.9 44.2 26.9 43.7 33.0 33.1 42.8 26.5 40.0 21.4 ATP5MC1 "ATP5G, ATP5G1" ENSG00000159199 "ATP synthase membrane subunit c locus 1" P05496 17 48892765-48895871 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 117.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.43e-2)" "prognostic favourable (3.88e-4)" "unprognostic (6.60e-2)" "unprognostic (2.09e-1)" "unprognostic (8.73e-2)" "unprognostic (4.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (9.42e-3)" "unprognostic (9.78e-2)" "prognostic favourable (8.24e-6)" "unprognostic (2.07e-2)" "unprognostic (5.60e-2)" "unprognostic (1.95e-1)" "unprognostic (2.33e-1)" 11.7 19.2 29.2 16.4 34.2 12.4 17.6 15.8 35.4 13.6 46.8 9.5 11.1 28.3 13.5 24.7 22.2 16.0 13.0 117.9 26.2 21.6 47.9 33.0 11.2 18.3 23.0 28.5 11.0 27.7 15.5 15.0 10.4 27.8 12.3 47.0 10.8 29.5 16.4 103.8 14.3 43.2 19.7 16.1 11.4 21.3 6.1 13.2 8.7 17.3 106.0 21.5 10.4 12.9 67.5 86.3 13.8 52.9 39.3 49.6 49.7 61.6 83.4 26.5 38.6 29.3 35.8 39.1 34.1 28.6 45.5 45.1 55.3 44.5 68.0 82.3 29.4 56.4 47.6 59.5 67.8 55.9 63.6 65.9 55.1 110.5 20.5 78.5 33.1 28.9 40.7 48.2 53.6 51.2 39.3 46.1 52.4 63.5 74.3 36.7 16.6 82.4 47.3 69.1 109.4 86.5 35.1 39.4 28.6 25.5 54.9 28.9 80.7 53.6 28.2 28.8 39.5 43.3 43.3 42.1 47.4 90.0 41.4 62.3 34.0 9.1 52.9 13.8 32.2 44.5 38.8 67.5 37.0 34.6 70.1 54.5 49.6 43.1 2.9 39.3 25.7 86.3 31.2 49.7 29.2 34.2 15.8 35.4 26.2 21.6 23.0 28.5 27.8 13.2 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved "HPA051469: " "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 39.1 60.1 52.8 34.8 48.0 49.7 64.3 47.4 72.1 46.4 57.0 49.5 38.2 50.3 57.0 63.3 52.3 71.2 48.2 107.6 45.9 43.7 60.3 60.1 46.8 105.6 49.3 57.9 67.3 99.2 47.9 50.8 34.0 42.2 46.4 73.3 49.7 69.1 43.1 165.8 50.3 45.4 53.3 51.3 51.6 57.4 38.1 32.9 82.1 46.2 92.9 67.0 47.4 41.7 112.1 133.4 30.2 96.4 71.7 99.0 126.2 27.4 58.9 62.2 56.3 42.9 105.0 29.2 24.2 54.6 72.5 49.8 20.1 65.1 33.4 59.6 47.4 26.6 79.4 56.3 64.5 55.8 95.2 91.1 47.6 41.4 93.5 69.2 45.5 116.5 83.8 70.2 117.0 93.0 64.5 98.7 73.5 72.1 70.6 168.9 53.0 65.8 71.4 59.0 82.9 88.4 34.6 32.4 59.5 32.7 38.1 81.7 123.7 126.4 44.4 35.6 49.1 27.2 37.5 51.8 43.2 24.2 52.9 73.1 54.3 30.2 96.4 27.1 68.9 89.6 75.8 112.1 89.2 73.6 133.4 99.5 99.0 81.4 22.0 71.7 79.5 103.0 92.7 126.2 52.8 48.0 47.4 72.1 45.9 43.7 49.3 57.9 42.2 32.9 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175184607 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 189.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favourable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavourable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favourable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 26.1 26.7 26.6 26.3 28.7 19.8 34.3 26.9 50.9 15.7 51.1 11.4 23.6 61.7 17.4 22.2 38.9 15.5 28.7 189.6 25.8 27.4 63.9 60.8 21.2 34.8 31.1 31.5 13.6 28.4 36.7 19.0 16.8 27.6 17.1 53.3 16.6 34.2 25.0 115.7 20.0 47.3 24.6 18.5 17.6 31.9 12.3 15.8 21.8 19.1 95.9 27.7 19.3 20.2 38.5 78.8 22.6 59.9 34.5 37.2 66.1 33.4 29.9 45.2 49.9 38.7 34.4 50.8 31.0 32.7 43.9 38.3 89.3 28.1 83.5 36.7 34.6 44.2 56.8 53.6 46.5 35.0 52.3 67.1 43.7 112.9 29.8 86.6 40.6 37.0 41.4 49.5 31.6 44.0 72.3 40.1 48.0 45.8 66.9 73.2 59.3 93.7 52.4 41.7 81.9 85.5 76.0 40.5 25.8 25.0 67.9 67.6 40.9 70.8 29.3 7.3 35.1 0.2 42.6 31.7 40.0 72.2 42.1 52.3 32.6 17.6 53.4 22.6 33.3 59.9 33.6 38.5 35.3 36.1 78.8 30.4 33.5 35.9 6.2 34.5 53.7 58.3 37.2 66.1 26.6 28.7 26.9 50.9 25.8 27.4 31.1 31.5 27.6 15.8 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria Mitochondria "HPA044798: " "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.2 64.1 60.6 72.3 67.8 85.2 39.7 58.0 73.2 59.3 66.4 103.1 67.3 34.7 33.7 65.6 61.8 56.7 59.1 81.9 45.5 101.9 36.0 82.5 115.2 65.9 73.4 55.9 68.7 92.8 53.3 84.3 76.4 47.1 57.9 99.1 93.5 59.5 126.4 45.0 108.5 38.7 37.0 54.0 141.0 98.3 23.0 53.2 30.6 47.0 83.4 41.8 68.2 43.2 29.4 45.1 44.5 75.9 61.1 99.8 57.8 62.1 75.3 22.2 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.1 46.5 67.0 54.6 56.5 52.5 37.4 47.9 38.4 36.4 32.3 44.7 48.7 25.5 46.1 50.6 31.5 54.0 75.5 20.0 22.5 99.7 75.0 86.2 111.5 58.7 95.4 33.0 65.1 44.4 41.7 42.2 44.5 62.0 27.9 41.3 70.8 82.2 125.0 78.8 121.8 50.1 49.0 55.5 69.5 85.8 65.1 51.1 34.8 46.9 53.2 53.6 65.8 51.5 32.7 31.1 28.8 66.8 65.3 107.7 80.6 48.1 65.8 35.8 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported Mitochondria 1400000 Mitochondria "HPA067267: , HPA070412: " "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 87.2 77.0 65.0 104.9 51.2 52.0 41.1 58.0 45.1 62.3 67.5 81.8 80.6 81.8 61.1 35.9 53.8 71.8 66.3 66.6 58.9 92.2 55.4 123.2 105.4 38.7 94.4 63.5 59.3 64.1 54.1 57.4 59.2 112.3 90.3 65.2 205.0 141.2 163.9 92.4 90.8 63.3 54.2 139.9 131.2 97.0 62.5 68.9 75.9 187.7 54.8 47.3 122.6 50.2 54.9 87.7 90.6 84.5 51.7 118.8 170.7 63.4 92.4 84.1 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044629 Approved Supported Mitochondria 590000 Mitochondria "HPA044629: " "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favourable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.5 11.2 29.5 28.5 25.5 28.6 23.6 22.1 25.2 20.3 21.6 28.2 35.0 42.8 46.2 24.0 27.6 29.6 30.9 22.6 34.1 19.5 67.6 10.5 17.0 26.2 38.4 32.4 30.4 29.3 25.0 23.9 27.3 30.9 35.9 28.3 38.7 53.6 48.0 18.7 31.2 36.9 24.7 47.0 52.8 18.6 23.4 17.7 33.3 54.1 16.3 39.3 35.9 26.8 16.8 18.8 14.3 25.2 16.4 22.4 43.5 12.5 44.8 20.9 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell line enhanced" "Detected in some" "RT4: 2.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA044629 Uncertain Supported Mitochondria Mitochondria "HPA044629: " "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.6 0.3 1.0 0.2 0.6 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 0.9 0.5 0.8 0.0 1.3 0.0 0.5 0.8 1.7 1.5 0.0 0.2 0.0 0.6 0.0 2.4 0.2 0.1 0.0 0.7 0.2 0.2 0.0 0.0 1.2 0.8 0.8 0.6 0.6 1.1 0.1 0.3 0.7 0.9 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: , HPA060520: " "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favourable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 38.3 44.4 38.5 36.6 46.1 47.9 38.0 30.1 34.2 37.8 33.1 38.3 27.3 40.3 31.8 30.8 32.8 49.5 36.3 51.2 33.3 50.0 44.9 37.6 58.9 30.4 54.3 31.3 50.2 49.4 25.6 27.4 42.4 27.3 43.3 41.5 114.1 52.4 77.5 30.0 84.9 33.7 33.6 36.6 57.6 54.7 33.3 39.8 25.2 47.3 56.7 58.6 64.6 22.8 14.9 23.3 40.1 24.6 33.2 56.4 56.4 34.9 31.0 25.0 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favourable (3.26e-9)" "prognostic favourable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.1 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.8 6.2 7.8 21.0 15.9 11.2 16.0 19.0 21.0 15.9 16.6 7.4 21.0 4.9 4.2 6.2 26.4 21.2 6.6 9.0 19.5 18.3 14.1 18.4 9.3 10.1 7.1 45.0 6.2 9.9 24.1 11.6 40.7 8.2 14.0 5.2 9.6 3.0 13.3 19.0 14.0 15.2 9.5 13.6 8.3 14.8 16.2 16.8 12.8 12.1 49.9 20.2 20.1 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria 1600000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 38.8 38.5 54.3 28.6 48.6 25.6 37.8 34.5 50.4 30.0 52.9 19.6 33.2 46.6 25.8 47.4 58.9 25.7 31.0 143.6 47.7 44.8 78.8 86.2 24.8 29.2 45.7 39.2 28.5 43.3 38.5 29.8 35.4 40.3 33.1 53.1 35.4 56.8 36.3 184.2 35.5 59.9 39.1 32.8 32.7 40.4 15.7 21.3 30.3 48.7 88.5 33.7 45.8 29.0 72.5 100.7 90.9 103.8 54.9 100.0 86.2 66.4 58.4 44.7 58.3 72.9 89.3 60.2 57.2 75.5 64.2 61.3 45.6 52.3 45.1 38.1 71.5 60.6 53.8 74.9 86.1 21.9 45.7 46.0 48.6 89.8 71.8 58.6 30.3 75.8 59.7 52.2 74.7 85.4 47.9 61.5 78.9 64.5 58.0 65.9 34.1 83.0 41.1 129.6 83.5 132.7 65.1 45.1 49.5 67.5 107.7 91.1 106.7 59.8 44.0 80.0 55.9 69.4 66.7 49.4 39.0 46.1 71.6 58.9 51.5 67.2 90.5 90.9 58.3 103.8 67.4 72.5 100.0 71.6 100.7 57.6 90.9 83.5 50.7 54.9 83.1 89.8 94.6 86.2 54.3 48.6 34.5 50.4 47.7 44.8 45.7 39.2 40.3 21.3 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria 720000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favourable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 39.8 46.8 49.0 20.3 43.6 23.0 32.6 30.8 46.6 25.9 48.6 26.1 22.4 43.0 24.0 57.4 45.2 21.6 19.2 148.9 41.1 37.1 72.8 111.0 18.7 22.2 47.0 27.0 23.9 37.4 31.2 37.5 33.9 45.7 32.6 47.9 33.9 47.1 37.5 164.7 18.7 57.9 46.9 32.8 25.0 37.6 21.0 25.8 31.4 32.1 69.9 29.9 42.0 23.1 87.8 102.4 80.9 91.5 69.1 95.2 112.2 41.6 30.0 38.3 43.0 41.2 38.0 47.5 36.9 42.9 36.1 35.3 68.9 32.9 51.4 24.5 36.4 22.9 51.2 44.2 39.8 44.9 54.4 107.1 61.0 68.4 46.6 78.2 35.1 37.1 54.6 34.5 31.0 41.9 66.8 63.2 52.6 46.6 54.1 79.2 68.8 54.5 42.3 74.4 97.0 77.0 57.0 43.7 48.6 62.0 62.7 56.8 45.3 70.4 31.6 27.6 33.1 25.7 31.7 63.1 103.1 65.0 42.4 81.8 34.5 69.2 88.8 80.9 60.3 91.5 64.0 87.8 80.2 74.6 102.4 71.6 79.6 78.0 56.9 69.1 89.7 96.4 95.2 112.2 49.0 43.6 30.8 46.6 41.1 37.1 47.0 27.0 45.7 25.8 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915980 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Enhanced Mitochondria 4000000 Mitochondria "CAB016209: AB_631361, HPA041394: " "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favourable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 32.6 26.8 49.3 27.7 43.5 34.9 37.8 35.0 44.8 28.7 45.0 21.6 24.2 48.2 25.1 34.3 44.2 28.9 30.3 139.4 40.8 36.7 61.3 57.5 20.6 31.5 45.6 38.4 38.0 40.1 29.5 19.2 25.1 46.4 32.5 52.4 27.2 38.8 28.6 130.6 28.7 57.5 34.8 29.3 27.3 43.2 25.4 20.1 42.7 37.4 98.0 36.2 39.4 26.5 71.9 94.0 48.5 71.5 46.8 73.3 112.2 41.9 19.7 54.9 53.8 37.7 48.4 61.1 24.0 42.2 40.4 39.7 57.7 40.7 56.2 20.7 36.4 23.8 59.1 82.0 47.9 41.9 58.9 84.3 31.5 57.3 43.5 63.8 29.2 49.2 50.2 39.1 64.3 55.6 67.6 73.0 51.9 43.2 48.7 62.7 62.6 58.3 50.3 54.2 106.1 110.7 37.3 44.4 25.7 41.2 61.7 54.6 62.2 70.5 31.3 26.6 31.7 47.4 27.2 48.2 52.6 58.9 49.1 109.6 38.3 33.4 69.9 48.5 44.5 71.5 53.0 71.9 58.8 52.9 94.0 59.0 73.3 61.5 17.2 46.8 62.6 55.9 70.1 112.2 49.3 43.5 35.0 44.8 40.8 36.7 45.6 38.4 46.4 20.1 ATP5S "ATPW, HSU79253" ENSG00000125375 "ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)" Q99766 14 50312326-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046967, HPA062690" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA046967: , HPA062690: " "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favourable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favourable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 5.5 5.0 8.4 6.0 12.5 10.0 7.0 5.6 11.0 5.9 5.2 13.9 7.9 9.4 7.0 7.6 7.9 6.0 5.7 9.0 8.8 9.0 6.8 5.0 5.4 6.6 10.0 10.5 6.3 7.3 3.3 11.2 3.5 10.1 5.6 4.6 8.3 5.6 4.7 11.6 11.7 6.5 3.6 12.4 5.4 5.4 19.8 10.3 5.1 10.1 8.0 6.1 5.1 5.1 17.0 14.2 15.4 14.1 9.2 12.9 9.6 7.8 2.0 3.8 2.1 4.7 8.4 11.8 2.9 3.6 4.9 7.2 3.3 5.9 8.9 2.6 4.6 4.8 1.3 2.7 3.1 5.1 2.4 4.8 4.1 13.8 1.1 7.0 7.3 7.5 6.7 0.7 1.4 3.6 1.5 15.9 3.3 7.1 1.7 5.3 2.4 4.2 5.1 5.6 4.7 2.4 11.2 5.4 3.5 2.3 7.5 5.3 8.0 3.6 2.2 6.3 9.0 3.8 2.9 8.0 5.2 5.2 1.0 5.3 5.0 9.8 10.4 15.4 11.4 11.4 10.0 17.0 9.4 11.0 7.7 14.1 11.9 12.9 1.1 9.2 14.1 14.2 10.8 9.6 8.4 12.5 5.6 11.0 8.8 9.0 10.0 10.5 10.1 10.3 ATPAF1 "ATP11, Atp11p, FLJ22351" ENSG00000123472 "ATP synthase mitochondrial F1 complex assembly factor 1" Q5TC12 1 46632737-46673867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 73.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028382, HPA044950" Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA028382: , HPA044950: " "unprognostic (1.34e-1)" "unprognostic (2.97e-3)" "unprognostic (1.18e-2)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (5.97e-2)" "unprognostic (3.53e-1)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (1.19e-2)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "prognostic favourable (5.33e-7)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-1)" "unprognostic (2.62e-1)" 20.6 32.0 32.9 7.5 34.5 7.9 14.0 15.9 31.0 11.1 15.2 16.1 9.3 12.0 7.8 10.8 10.6 9.8 9.0 73.4 22.3 20.8 33.3 31.9 7.5 8.6 28.2 24.9 10.6 18.8 39.5 14.6 11.0 28.5 11.6 16.9 11.9 15.9 10.8 66.9 5.7 11.7 12.7 18.6 6.9 12.8 13.4 18.2 10.8 13.0 13.1 9.4 9.8 6.1 3.1 2.4 5.8 4.2 9.2 6.6 1.8 20.4 16.7 22.6 20.1 24.7 20.0 18.9 15.3 19.2 23.1 18.7 13.3 8.9 12.1 20.6 19.3 15.9 35.5 19.9 31.2 26.5 28.1 21.4 20.8 23.1 19.9 21.1 1.3 19.5 23.9 24.7 21.6 14.4 9.8 24.1 17.6 18.5 31.1 11.8 35.5 25.2 13.5 6.1 26.4 26.3 16.3 26.7 20.0 25.9 27.6 39.9 25.5 29.9 12.4 7.9 19.6 15.9 20.8 30.0 27.2 8.3 13.0 8.2 14.8 0.0 2.5 5.8 3.5 4.2 4.6 3.1 3.7 4.0 2.4 1.7 5.2 2.4 2.1 9.2 1.7 1.8 6.6 1.8 32.9 34.5 15.9 31.0 22.3 20.8 28.2 24.9 28.5 18.2 ATPAF2 "ATP12, Atp12p, LP3663, MGC29736" ENSG00000171953 "ATP synthase mitochondrial F1 complex assembly factor 2" Q8N5M1 17 17977409-18039209 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023329, HPA059422" Supported Enhanced Cytosol Cytosol "HPA023329: AB_1845209, HPA059422: " "unprognostic (3.16e-2)" "unprognostic (1.98e-2)" "unprognostic (4.40e-2)" "prognostic favourable (4.95e-4)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.70e-3)" "unprognostic (1.67e-2)" "prognostic favourable (6.00e-5)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (5.15e-1)" "unprognostic (2.62e-2)" 9.8 23.1 14.2 11.0 12.5 18.0 11.4 18.1 20.9 10.3 14.3 17.1 12.7 11.5 9.9 12.1 16.1 11.1 8.9 25.3 12.4 12.6 19.1 21.6 9.8 12.5 12.7 11.6 9.8 14.5 20.0 14.2 11.5 13.0 11.3 14.1 15.4 19.5 10.7 28.3 16.4 13.8 11.2 10.9 13.6 12.9 17.3 12.5 12.9 14.2 13.5 19.1 13.0 10.4 13.0 24.2 6.9 20.6 3.9 6.0 9.7 8.1 15.2 10.1 9.6 10.1 11.0 10.2 7.2 10.6 15.6 13.3 20.2 12.5 16.5 16.3 12.5 12.8 9.6 15.5 13.7 13.1 7.5 3.6 9.9 11.6 17.1 5.2 11.4 13.1 11.1 14.0 7.9 17.8 5.7 5.8 8.5 16.7 12.0 7.9 6.8 8.7 12.5 17.7 18.8 12.5 7.3 6.5 8.9 9.6 5.0 8.9 16.0 10.4 7.4 3.9 8.3 14.5 6.9 4.0 5.0 6.0 7.2 7.6 20.3 3.5 20.6 6.9 4.8 14.0 5.3 13.0 3.7 4.6 24.2 9.4 5.7 4.4 1.4 3.9 10.1 20.5 6.0 9.7 14.2 12.5 18.1 20.9 12.4 12.6 12.7 11.6 13.0 12.5 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: " "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favourable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.5 31.5 13.4 29.2 19.3 15.1 10.9 11.2 14.3 16.9 16.0 23.5 20.9 27.2 18.4 9.7 21.5 28.6 15.7 18.4 12.5 14.0 15.6 16.0 24.3 20.3 21.0 14.9 16.4 14.6 17.8 28.9 17.6 17.7 21.1 15.4 15.4 15.1 15.5 14.8 14.9 18.7 19.5 17.5 15.6 10.5 11.0 18.2 20.1 11.0 19.0 42.1 8.7 13.9 8.8 12.6 13.1 16.6 17.2 22.3 18.3 15.6 34.1 7.4 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 COX17 ENSG00000138495 "COX17, cytochrome c oxidase copper chaperone" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria 1000000 Mitochondria "HPA042226: , HPA048158: " "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 16.6 42.9 20.0 18.2 19.4 21.2 30.4 21.1 20.4 10.2 16.8 9.2 43.5 22.0 11.9 22.9 11.7 11.0 13.6 53.5 17.2 23.0 27.6 37.0 17.8 20.3 23.2 15.2 7.9 39.9 21.1 45.7 18.2 33.7 17.2 16.2 19.4 25.6 33.3 80.4 8.7 21.0 15.4 20.8 15.3 22.3 13.4 16.7 11.1 16.6 37.1 17.2 13.7 20.1 35.6 53.5 52.8 46.9 19.8 33.9 22.0 27.2 28.5 15.6 3.8 6.0 5.6 5.6 15.2 9.2 14.1 14.7 25.1 19.8 19.7 18.5 7.2 10.3 15.4 15.5 8.5 24.8 18.5 17.1 22.6 19.8 6.9 24.9 32.0 6.4 15.0 8.8 12.1 9.1 13.9 47.5 16.3 44.4 25.0 35.9 17.5 47.6 11.1 10.5 32.6 21.9 16.1 26.0 11.4 18.8 18.1 22.8 22.7 39.7 7.2 12.1 19.0 7.6 20.9 33.8 33.7 41.8 17.2 19.1 20.8 50.1 22.4 52.8 21.8 33.2 23.0 35.6 27.2 24.7 22.9 27.2 21.7 22.6 17.7 19.8 46.9 53.5 33.9 22.0 20.0 19.4 21.1 20.4 17.2 23.0 23.2 15.2 33.7 16.7 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favourable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.1 72.0 48.9 65.3 90.7 85.1 84.5 40.3 82.5 76.4 38.2 121.7 66.9 72.4 49.6 64.2 88.9 69.6 81.0 68.0 24.6 71.9 40.4 60.9 118.2 81.8 36.6 30.1 98.6 125.8 62.5 85.4 79.7 67.9 29.7 64.7 159.1 73.4 113.6 65.7 84.8 83.3 30.8 63.3 113.3 87.6 58.2 47.3 85.4 54.3 65.3 79.6 102.4 56.0 38.3 44.4 35.2 43.1 60.0 57.0 166.4 58.5 72.7 43.0 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637888-31645006 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.7" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 11 "B-cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favourable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavourable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 9.9 0.7 1.6 1.7 1.9 0.1 7.9 0.7 2.5 4.7 2.2 1.5 0.9 1.1 5.9 3.5 7.1 2.6 5.4 15.5 1.7 1.4 2.0 0.5 24.6 4.9 2.4 1.0 1.9 1.9 2.1 1.1 60.7 2.7 5.2 1.6 4.1 2.4 2.8 12.8 2.5 2.7 3.9 1.2 0.8 2.0 1.5 2.1 0.5 8.0 7.5 2.3 3.7 3.7 2.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.7 2.5 1.7 1.4 2.4 1.0 2.7 2.1 COX5A ENSG00000178741 "Cytochrome c oxidase subunit 5A" P20674 15 74919791-74938168 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 209.7;skeletal muscle: 222.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027526 Supported 5400000 "HPA027526: AB_10602802" "unprognostic (7.32e-2)" "prognostic favourable (2.15e-4)" "unprognostic (4.06e-2)" "unprognostic (9.85e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (3.79e-2)" "unprognostic (9.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.77e-1)" "unprognostic (8.62e-2)" "prognostic favourable (6.06e-7)" "unprognostic (9.78e-2)" "unprognostic (2.22e-1)" "unprognostic (1.30e-1)" "unprognostic (3.81e-3)" 22.4 20.1 30.4 25.9 29.1 20.6 36.1 22.4 57.9 15.0 70.8 12.1 21.6 51.5 11.6 19.3 31.6 14.6 22.7 209.7 26.7 25.4 42.6 49.4 17.7 29.0 32.7 27.3 8.7 41.1 27.7 16.4 15.0 26.7 15.6 65.7 13.7 32.2 23.1 222.8 17.2 49.4 15.9 20.9 17.3 31.7 26.2 12.2 21.9 19.9 86.5 30.6 17.9 15.1 52.2 81.2 47.3 80.6 58.8 64.1 65.7 34.5 38.5 47.7 41.6 29.4 34.0 52.5 31.5 27.9 40.4 37.8 42.8 43.9 79.3 38.8 27.1 68.5 112.6 45.8 33.9 44.8 105.1 65.8 40.1 53.2 36.9 75.1 41.4 34.5 49.7 25.2 57.1 47.2 60.4 54.0 40.3 27.2 62.7 57.8 50.6 57.0 58.5 45.7 92.1 59.0 58.6 69.9 30.0 47.7 71.7 98.6 35.9 61.3 31.9 30.6 28.9 38.2 49.9 61.9 113.5 87.9 32.8 99.8 27.8 47.3 65.5 36.1 37.6 80.6 44.9 52.2 46.7 44.2 81.2 37.8 33.2 38.5 15.8 58.8 72.1 64.7 64.1 65.7 30.4 29.1 22.4 57.9 26.7 25.4 32.7 27.3 26.7 12.2 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favourable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.5 22.9 14.1 23.4 16.7 15.2 61.0 25.2 14.1 16.7 18.7 63.1 20.5 33.0 54.2 16.1 29.9 16.3 25.3 7.6 25.7 69.2 44.4 25.3 75.3 32.1 42.2 32.6 28.1 22.4 16.1 12.6 14.3 32.6 14.6 12.9 48.4 26.6 61.1 27.8 120.1 26.1 24.3 49.4 22.5 30.1 28.1 30.0 24.5 29.6 47.3 15.7 44.1 26.0 15.3 26.1 24.5 16.2 38.1 36.0 25.2 27.8 36.2 15.8 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria Mitochondria "HPA062394: " "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favourable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 46.7 100.0 57.0 59.5 43.9 37.4 69.8 29.8 39.8 52.9 45.2 120.9 47.7 98.5 89.1 42.0 78.2 55.5 65.3 34.4 59.0 119.6 52.8 57.2 88.6 40.6 57.9 38.0 45.0 80.7 48.3 57.3 44.5 51.8 30.8 43.9 130.8 83.4 146.6 51.9 146.8 57.1 38.2 92.2 83.5 112.7 75.2 65.4 54.6 53.6 70.0 96.1 66.1 33.5 33.0 40.8 34.0 41.4 47.9 65.8 76.2 51.8 56.8 43.9 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 COX6A2 ENSG00000156885 "Cytochrome c oxidase subunit 6A2" Q02221 16 31427731-31428428 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8" "Cell line enriched" "Detected in some" 4 "U-266/84: 14.3" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 125 "NK-cell: 12.5" "Lineage enriched" "Detected in single" 125 "NK-cells: 12.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.66e-1)" "unprognostic (1.73e-3)" "unprognostic (2.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.68e-2)" "unprognostic (3.88e-1)" "unprognostic (5.61e-2)" "unprognostic (7.20e-2)" "unprognostic (8.71e-2)" "unprognostic (6.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-1)" 3.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 9.3 5.6 0.1 0.1 398.6 0.1 0.3 0.2 0.9 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.8 0.1 0.0 2.3 0.1 0.9 8.4 0.1 421.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 5.5 230.8 11.4 0.1 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 0.0 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648223-35658861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria 1200000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favourable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 37.2 32.2 62.1 32.1 58.7 46.2 42.8 31.1 57.6 34.1 65.0 25.2 41.2 52.7 27.1 70.2 52.4 36.3 39.8 132.5 51.5 52.2 61.1 68.9 24.7 40.4 57.4 60.2 29.2 41.1 41.4 28.8 30.2 39.2 30.2 77.1 31.8 54.9 44.2 168.4 35.1 63.2 37.6 38.7 30.7 42.0 21.0 29.0 42.7 37.6 110.6 52.7 33.8 31.6 110.6 115.5 111.1 116.1 61.2 107.9 167.5 42.8 102.5 44.5 59.3 58.5 59.9 41.3 34.9 53.0 57.7 58.4 83.6 43.2 48.4 61.9 55.0 31.5 71.3 59.3 56.8 56.2 48.9 82.8 54.8 81.9 46.2 74.4 43.2 70.3 74.4 53.9 31.3 56.0 51.6 72.5 58.0 83.0 52.2 54.9 33.0 69.1 45.3 48.9 80.0 131.6 85.7 39.1 44.7 56.2 96.9 34.5 38.4 80.8 33.4 33.4 38.3 35.4 54.3 43.5 52.2 65.7 44.1 57.7 42.9 87.7 108.6 94.7 65.5 116.1 62.4 110.6 90.5 76.1 111.8 92.7 89.6 79.4 111.1 61.2 107.8 115.5 107.9 167.5 62.1 58.7 31.1 57.6 51.5 52.2 57.4 60.2 39.2 29.0 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.1;SCLC-21H: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavourable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.1 0.1 0.2 0.2 1.7 0.7 0.2 0.2 0.8 0.6 0.0 1.7 0.1 0.3 0.1 1.7 0.2 2.4 0.4 0.5 0.0 0.4 0.2 0.0 0.4 0.1 0.2 0.6 0.5 0.1 0.0 0.2 0.0 0.4 9.5 0.3 0.3 0.1 0.0 0.4 0.0 0.3 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Enhanced Mitochondria 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: " "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 16.7 6.7 7.9 32.2 18.0 13.1 13.2 5.5 5.2 3.8 4.3 6.8 35.9 40.7 41.6 8.5 22.3 4.5 45.6 6.3 7.3 11.4 84.4 8.1 19.8 11.7 38.9 26.1 12.1 60.7 3.1 7.0 5.6 5.9 73.1 6.3 16.0 40.4 35.8 15.1 15.6 46.9 2.6 39.8 57.2 89.2 24.5 14.9 3.8 83.6 40.8 58.9 24.9 4.8 28.6 37.2 30.2 7.8 18.2 14.6 24.1 40.2 15.8 25.3 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 COX7A1 "COX7A, COX7AH" ENSG00000161281 "Cytochrome c oxidase subunit 7A1" P24310 19 36150922-36152869 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 114.9;skeletal muscle: 404.3" "Cell line enhanced" "Detected in some" "ASC diff: 24.0;ASC TERT1: 17.6;BJ: 16.1;BJ hTERT+: 13.4;fHDF/TERT166: 24.6;HHSteC: 16.0;HSkMC: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.48e-2)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "unprognostic (6.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (9.93e-2)" "unprognostic (1.92e-1)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (7.84e-3)" "unprognostic (7.27e-3)" "unprognostic (9.44e-2)" "unprognostic (6.23e-2)" "unprognostic (1.54e-2)" 15.7 8.1 5.3 2.5 3.6 1.2 8.8 2.1 13.1 4.1 8.0 0.8 2.6 2.0 3.9 6.1 6.6 3.1 5.0 114.9 3.3 2.4 5.0 1.6 4.0 2.7 2.6 4.6 4.2 3.5 6.0 7.9 2.6 1.7 5.9 2.3 5.9 6.2 7.1 404.3 2.0 2.2 12.3 1.4 3.1 3.6 1.6 1.5 1.6 5.1 59.7 2.6 7.0 4.7 0.0 1.3 1.4 1.9 0.0 0.1 0.3 0.1 2.6 0.2 0.0 24.0 17.6 0.1 16.1 13.4 0.5 0.0 0.0 0.8 0.6 6.7 24.6 0.3 0.0 0.0 0.1 0.0 0.8 0.1 0.9 0.1 16.0 0.0 0.2 16.6 0.0 0.0 0.0 1.8 0.2 0.2 0.0 0.3 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 3.6 0.0 0.6 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.5 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.4 0.0 0.5 0.4 0.1 0.3 5.3 3.6 2.1 13.1 3.3 2.4 2.6 4.6 1.7 1.5 COX7A2 "COX7AL, COXVIIa-L" ENSG00000112695 "Cytochrome c oxidase subunit 7A2" 6 75237675-75250323 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 157.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.98e-2)" "unprognostic (2.15e-2)" "unprognostic (1.34e-1)" "unprognostic (5.67e-3)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (7.70e-2)" "unprognostic (2.73e-3)" "unprognostic (7.44e-2)" "unprognostic (1.74e-1)" "prognostic favourable (3.43e-5)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" 26.9 25.3 49.7 18.8 55.3 26.5 30.2 27.0 54.9 19.5 55.9 12.3 37.0 35.3 16.9 41.5 29.7 20.3 23.4 76.3 38.0 32.9 44.8 51.7 17.8 23.9 48.9 34.6 12.6 46.9 19.4 27.2 18.3 36.8 24.0 61.5 18.3 35.7 27.1 38.2 19.1 35.6 29.0 39.4 18.1 36.4 62.8 27.5 17.4 22.4 47.1 27.1 23.4 16.7 109.1 130.5 94.1 108.8 76.9 110.3 157.6 15.1 34.8 45.7 37.5 27.3 31.0 33.1 37.1 34.1 37.1 40.2 62.6 23.2 24.8 32.9 33.4 33.0 31.8 40.1 46.5 45.4 65.2 37.2 108.9 82.2 28.1 39.6 43.9 33.6 53.7 34.3 22.5 42.9 32.8 36.1 50.0 70.7 16.8 43.1 28.6 63.8 27.5 23.1 65.3 59.1 99.1 31.3 37.9 23.1 42.3 37.1 25.9 111.8 20.8 16.5 29.9 13.1 42.0 51.2 55.7 27.5 18.7 45.4 31.9 92.9 100.0 94.1 78.3 107.7 83.0 109.1 102.4 93.5 103.6 90.2 101.1 93.4 74.7 76.9 108.8 130.5 110.3 157.6 49.7 55.3 27.0 54.9 38.0 32.9 48.9 34.6 36.8 27.5 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria Mitochondria Nucleoli "CAB073545: , HPA059124: " "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 37.5 24.1 26.8 29.0 46.0 65.6 32.0 31.2 45.6 28.5 36.4 26.4 27.2 33.3 31.3 35.7 16.9 31.9 33.0 41.8 51.2 24.5 22.5 17.3 46.8 54.2 33.8 25.1 64.3 66.6 27.9 67.4 40.1 32.8 57.2 44.1 30.6 40.3 56.3 26.2 25.1 22.0 46.5 28.3 40.8 30.5 31.8 36.4 13.1 32.9 89.4 23.6 39.5 30.2 25.9 33.9 31.3 30.4 47.0 52.5 25.0 36.6 36.8 21.9 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 COX7B ENSG00000131174 "Cytochrome c oxidase subunit 7B" P24311 X 77899438-77907373 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058041 Uncertain "HPA058041: " "unprognostic (1.24e-2)" "unprognostic (1.76e-3)" "unprognostic (8.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (2.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.26e-1)" "unprognostic (8.10e-2)" "prognostic favourable (6.80e-6)" "unprognostic (8.58e-2)" "unprognostic (4.62e-1)" "unprognostic (6.38e-2)" "prognostic favourable (2.43e-4)" 9.4 11.5 23.7 9.2 26.8 18.0 18.2 15.4 32.3 13.1 22.5 4.1 19.8 18.0 8.1 16.4 17.1 10.4 10.7 81.4 21.9 20.6 34.6 28.8 9.7 9.9 24.0 22.9 7.2 15.1 11.1 11.7 8.6 21.3 9.6 22.9 6.9 14.5 18.1 69.4 9.2 19.7 15.9 19.0 8.1 14.5 3.0 12.9 4.8 12.2 62.7 10.8 11.3 9.7 16.5 23.0 19.4 25.9 17.2 22.2 19.1 8.1 20.7 11.8 12.1 13.4 11.4 8.1 6.7 10.3 13.2 15.4 24.1 13.8 12.6 10.2 10.9 13.3 31.9 18.4 15.6 5.7 31.3 13.7 29.3 22.9 11.2 21.4 8.6 14.5 15.7 15.8 14.0 14.0 15.8 22.8 14.1 24.0 12.8 20.6 12.1 56.4 11.6 17.6 34.7 35.8 26.3 11.5 7.5 17.4 22.5 10.6 8.7 11.6 9.2 5.9 8.8 13.0 5.9 5.1 13.1 15.8 13.9 28.5 7.7 19.4 20.8 14.0 15.6 25.9 21.1 16.5 20.1 19.0 23.0 13.4 20.7 22.2 15.5 17.2 24.5 17.1 18.4 19.1 23.7 26.8 15.4 32.3 21.9 20.6 24.0 22.9 21.3 12.9 COX7B2 ENSG00000170516 "Cytochrome c oxidase subunit 7B2" Q8TF08 4 46734827-46909235 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 43.9" "Cell line enriched" "Detected in some" 15 "Karpas-707: 27.8" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.82e-1)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 3.4 0.2 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.4 0.1 0.0 3.4 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX7C ENSG00000127184 "Cytochrome c oxidase subunit 7C" P15954 5 86617904-86620962 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 298.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046647 Approved "HPA046647: " "unprognostic (1.45e-1)" "unprognostic (1.74e-2)" "unprognostic (9.10e-2)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (1.04e-1)" "unprognostic (3.70e-1)" "unprognostic (4.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.23e-5)" "unprognostic (4.56e-2)" "unprognostic (2.06e-1)" "unprognostic (1.46e-1)" "unprognostic (4.46e-2)" 43.3 60.4 76.4 35.7 68.1 36.8 49.6 41.1 65.0 35.0 74.8 22.7 44.0 76.0 50.7 55.5 53.7 32.6 44.4 150.2 61.8 57.6 91.6 83.1 36.0 66.1 72.0 44.2 51.9 88.8 39.3 47.3 26.5 51.5 42.7 53.9 36.2 127.6 46.1 298.4 28.0 73.3 71.5 39.7 35.5 54.2 31.2 32.1 39.7 56.3 84.9 40.1 53.9 58.0 92.8 91.6 54.1 73.4 51.2 96.5 113.9 54.3 62.8 56.4 105.2 52.7 53.1 63.3 42.3 33.9 28.1 39.7 72.9 99.1 74.0 46.2 31.2 59.2 49.9 80.3 46.1 54.9 76.6 59.2 97.1 75.2 44.2 70.3 70.6 62.1 69.3 35.7 49.1 44.8 35.8 87.2 41.0 108.5 72.9 88.7 60.0 181.9 70.9 65.8 136.2 83.8 104.2 70.5 51.5 40.6 95.7 89.1 97.2 96.0 44.3 26.2 47.9 44.7 80.7 84.5 97.7 85.5 67.0 82.3 49.3 38.0 72.1 54.1 58.1 73.4 72.5 92.8 91.1 71.8 91.6 79.4 96.5 84.2 7.3 51.2 68.2 85.2 80.2 113.9 76.4 68.1 41.1 65.0 61.8 57.6 72.0 44.2 51.5 32.1 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974607-63976543 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 275.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055942 Supported "HPA055942: " "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favourable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 41.4 42.8 54.0 32.8 53.4 50.4 47.4 40.9 60.3 30.2 76.6 18.2 35.5 69.0 23.3 31.2 63.3 35.9 43.9 154.9 41.5 41.0 78.8 61.1 38.1 50.8 54.5 34.0 24.7 43.0 38.7 37.6 32.2 35.7 37.9 51.6 35.9 54.4 50.2 275.5 31.2 66.7 29.9 37.0 31.0 50.8 18.7 24.3 44.6 42.4 121.7 34.8 38.8 29.8 52.7 114.8 87.8 108.6 51.0 75.7 80.3 59.6 79.6 51.4 51.0 22.0 27.0 37.2 31.6 35.5 62.8 48.9 53.2 49.0 28.4 70.0 43.9 59.6 39.6 54.5 21.6 41.8 68.7 41.4 64.6 62.3 35.4 41.7 53.9 34.7 41.4 50.3 40.6 38.9 48.1 62.1 39.5 155.2 59.0 142.0 46.7 139.9 46.3 41.3 119.6 50.8 50.4 46.6 66.0 37.6 54.7 77.5 80.4 45.3 23.9 36.6 49.6 78.3 36.8 78.0 61.1 43.8 47.5 41.2 43.8 78.3 101.8 87.8 57.5 108.6 42.4 52.7 63.2 56.4 114.8 46.4 49.0 53.4 71.3 51.0 97.9 113.0 75.7 80.3 54.0 53.4 40.9 60.3 41.5 41.0 54.5 34.0 35.7 24.3 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Cell line enriched" "Detected in some" 9 "U-937: 17.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA003127 Approved "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell line enhanced" "Detected in all" "PC-3: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favourable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.4 13.4 28.0 11.1 12.3 25.8 12.8 15.6 32.7 21.5 35.2 27.8 31.5 28.9 17.1 33.0 29.2 25.4 12.3 19.3 38.7 33.8 42.5 32.2 19.9 19.9 22.1 17.9 31.8 20.8 41.3 18.9 30.7 28.2 17.0 79.8 37.3 18.5 15.5 151.2 33.0 17.9 55.2 26.8 35.8 36.0 15.9 35.7 49.4 26.2 40.6 30.6 14.4 20.8 44.4 23.0 38.9 31.3 22.7 23.4 26.5 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 EARS2 "KIAA1970, MSE1" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23522014-23557731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavourable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favourable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 8.4 19.0 11.0 8.5 19.0 2.7 13.6 13.4 16.8 11.1 10.0 10.8 12.7 6.4 11.4 10.2 10.5 13.1 7.8 14.9 10.9 11.9 14.5 18.3 7.3 8.1 9.9 14.0 12.0 18.9 32.7 10.9 12.4 10.3 11.3 11.0 8.8 16.4 11.7 17.3 11.1 6.9 8.3 9.3 7.6 9.2 12.6 10.4 6.3 14.5 9.0 11.0 8.6 16.9 3.0 6.2 0.5 5.5 10.6 7.9 3.3 8.1 16.4 7.7 12.4 5.4 7.8 9.4 9.0 6.9 11.2 9.4 11.9 8.2 11.3 9.3 8.3 9.1 29.1 16.6 10.7 4.5 14.1 6.5 10.1 20.2 8.7 7.2 8.2 8.3 9.9 10.0 14.2 5.0 20.3 6.0 7.9 17.1 7.2 5.2 20.4 5.7 12.9 8.9 21.7 14.1 7.0 13.8 10.1 7.1 13.4 7.2 18.1 8.2 4.0 8.8 7.8 9.7 11.4 11.0 10.4 9.1 9.0 10.1 13.0 0.0 2.8 0.3 4.2 3.6 7.9 3.0 4.7 4.3 6.2 3.0 4.6 4.5 0.5 10.6 5.5 4.5 3.4 3.3 11.0 19.0 13.4 16.8 10.9 11.9 9.9 14.0 10.3 10.4 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein alpha subunit" P13804 15 76215355-76311472 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria 6300000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favourable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 18.8 39.9 12.8 16.4 13.6 10.7 26.1 7.6 13.4 8.6 26.4 7.3 9.6 27.5 10.1 11.1 18.9 7.7 12.6 84.4 13.3 8.5 36.4 78.3 9.8 15.7 11.9 12.9 7.8 28.1 7.6 11.0 24.0 11.8 11.2 26.0 9.4 15.8 10.8 84.0 12.3 29.2 17.3 11.8 11.7 18.5 9.7 10.8 10.8 11.9 37.9 12.8 14.8 11.5 24.6 50.7 25.2 38.8 36.0 29.3 39.4 21.7 35.9 23.8 24.9 26.8 28.6 37.5 26.3 30.5 34.2 30.7 31.7 40.7 36.5 26.5 26.1 55.9 92.3 36.6 39.9 43.8 18.0 39.7 26.1 36.6 21.9 37.9 29.7 21.4 34.7 17.3 28.9 34.5 37.5 38.0 35.0 34.3 7.8 31.7 18.5 10.8 34.3 29.6 48.8 37.6 70.1 24.9 12.6 39.9 91.2 36.1 46.8 40.2 20.2 33.4 22.7 29.2 31.7 18.5 38.0 45.0 24.0 50.5 23.6 11.2 38.8 25.2 22.1 34.5 20.8 24.6 20.8 22.7 50.7 20.2 17.0 21.1 9.9 36.0 28.4 20.3 29.3 39.4 12.8 13.6 7.6 13.4 13.3 8.5 11.9 12.9 11.8 10.8 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell line enriched" "Detected in all" 4 "Hep G2: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favourable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favourable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.2 34.2 4.7 13.0 15.2 17.8 7.5 9.0 6.9 7.3 7.3 28.7 21.8 13.2 9.2 14.5 11.7 9.4 19.2 2.2 19.7 36.6 10.4 20.9 185.6 16.7 9.9 7.8 27.6 5.7 9.9 10.2 6.2 15.6 14.9 9.4 26.8 10.3 9.4 3.0 42.3 11.5 12.8 24.7 10.0 15.2 10.6 5.1 19.9 5.7 10.3 14.9 9.6 8.7 7.6 8.0 8.2 8.2 22.9 13.9 11.8 39.0 14.8 19.6 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 ETFDH ETFQO ENSG00000171503 "Electron transfer flavoprotein dehydrogenase" Q16134 4 158672125-158709623 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 72.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041978 Enhanced "HPA041978: AB_10795605" "unprognostic (7.19e-2)" "unprognostic (2.28e-1)" "unprognostic (2.90e-2)" "unprognostic (5.92e-3)" "unprognostic (1.91e-1)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (7.17e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-2)" "prognostic favourable (5.76e-10)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.85e-3)" "unprognostic (1.74e-1)" 11.3 20.1 7.0 3.9 8.6 2.8 12.9 10.3 8.2 5.1 12.5 6.5 6.1 23.0 5.7 6.4 10.9 4.3 5.2 47.8 7.2 5.0 17.3 72.8 4.3 2.9 8.0 5.3 5.0 8.9 11.4 8.8 9.0 8.5 5.2 10.5 7.4 7.2 5.6 33.7 7.7 20.4 8.5 4.8 4.8 9.2 4.1 8.4 4.9 6.0 17.5 5.4 5.8 6.1 5.8 11.0 24.5 13.5 6.2 9.2 5.4 5.6 3.5 5.9 10.7 25.6 15.3 2.8 10.0 10.0 7.4 7.2 1.9 12.5 13.8 2.1 12.1 6.6 11.4 9.9 10.4 21.9 8.3 12.7 8.1 3.3 11.2 10.9 12.1 14.1 12.5 8.0 6.8 14.4 7.0 26.1 11.8 5.8 10.5 5.5 2.3 8.6 8.5 2.0 9.7 11.1 4.9 9.0 3.5 10.0 19.9 9.4 13.5 8.4 6.4 6.0 3.1 8.8 5.1 14.7 18.3 9.4 12.4 9.2 6.4 2.5 13.5 24.5 6.7 13.3 8.1 5.8 6.3 6.8 11.0 5.4 7.8 6.6 4.6 6.2 11.7 8.4 9.2 5.4 7.0 8.6 10.3 8.2 7.2 5.0 8.0 5.3 8.5 8.4 IK "RED, RER" ENSG00000113141 "IK cytokine" Q13123 5 140647058-140662479 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048798 Supported Enhanced "Nuclear speckles" "Nuclear speckles" "HPA048798: " "unprognostic (9.90e-2)" "prognostic favourable (1.29e-4)" "unprognostic (6.99e-2)" "unprognostic (1.49e-2)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "prognostic unfavourable (2.32e-7)" "unprognostic (1.19e-1)" "unprognostic (4.87e-2)" "unprognostic (4.37e-2)" "unprognostic (8.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-3)" "unprognostic (3.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.26e-2)" "unprognostic (2.83e-1)" 42.0 37.7 35.6 35.3 45.6 61.3 36.9 56.3 41.6 40.2 38.8 44.1 31.3 29.7 44.3 41.0 45.8 79.4 28.9 40.1 36.6 35.6 40.7 36.7 37.0 43.3 34.2 39.2 48.3 27.4 42.3 47.8 39.6 41.6 43.8 38.9 31.0 37.2 41.6 71.4 39.6 40.0 48.3 39.4 45.6 34.1 54.4 45.4 69.5 42.0 37.8 49.4 55.4 37.4 54.3 39.2 76.6 50.0 53.9 76.4 60.5 32.6 35.4 31.7 46.0 35.3 31.1 38.0 38.7 41.2 43.2 43.6 49.5 37.3 38.0 50.0 40.1 33.8 47.1 52.9 50.3 55.8 37.3 37.7 59.6 31.4 37.7 59.9 39.1 34.0 34.7 43.1 38.7 36.5 38.6 35.8 38.3 28.8 52.2 59.0 21.1 37.7 39.5 47.6 37.9 32.6 30.8 29.5 32.7 47.8 44.7 45.7 51.1 46.4 39.2 36.3 25.0 30.5 46.3 51.8 78.4 53.5 41.4 45.4 27.5 76.6 39.2 65.6 57.0 44.0 50.3 54.3 61.8 58.0 39.2 50.1 65.7 61.1 66.1 53.9 50.0 37.3 76.4 60.5 35.6 45.6 56.3 41.6 36.6 35.6 34.2 39.2 41.6 45.4 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.7 7.3 3.0 7.5 11.6 9.5 7.9 5.4 11.1 3.4 6.3 1.3 13.7 14.6 12.6 8.1 16.0 0.9 2.8 3.6 3.2 10.5 10.6 2.3 6.7 11.8 2.1 17.3 7.0 12.5 3.4 8.2 5.4 5.2 5.8 4.2 14.6 7.0 6.8 5.3 4.1 7.5 3.3 18.6 7.4 1.9 1.6 9.0 3.8 13.9 4.9 10.5 0.3 2.5 5.3 7.9 4.4 1.4 4.9 1.5 4.7 4.9 4.1 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 MT-ATP6 "ATP6, ATPase-6, MTATP6, RP, Su6m" ENSG00000198899 "Mitochondrially encoded ATP synthase membrane subunit 6" P00846 MT 8527-9207 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 419.0;skeletal muscle: 475.3" "Cell line enhanced" "Detected in all" "HeLa: 1161.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 419.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.97e-1)" "unprognostic (4.16e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" "unprognostic (8.45e-3)" "unprognostic (1.66e-1)" "prognostic favourable (3.79e-4)" "unprognostic (6.47e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-2)" "prognostic favourable (7.64e-4)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.37e-1)" "unprognostic (3.56e-1)" "unprognostic (2.52e-3)" 85.2 89.2 126.0 25.1 159.3 20.1 29.6 45.2 81.2 20.1 60.3 75.6 23.5 30.9 42.8 19.8 24.6 309.5 122.3 90.2 154.4 166.8 18.0 19.3 102.8 26.5 54.7 36.2 22.0 34.1 37.6 59.4 66.8 35.6 475.3 62.5 52.6 27.9 61.3 20.7 58.4 27.7 22.4 18.6 23.0 15.7 110.2 58.9 419.0 88.2 72.3 90.5 35.3 98.7 162.9 113.7 178.4 217.2 49.9 74.3 145.5 26.6 19.7 33.3 191.6 108.6 175.9 61.8 78.5 215.2 11.8 113.5 36.6 125.7 103.1 154.0 1161.8 331.5 36.9 91.1 199.6 81.3 100.7 35.3 34.2 34.9 101.3 128.4 76.7 278.0 56.1 242.7 29.9 67.5 70.7 48.5 108.4 204.5 250.6 65.0 83.4 52.1 111.3 105.2 119.0 313.0 184.2 80.3 118.7 132.6 103.9 56.7 74.9 122.0 70.1 194.6 44.9 419.0 88.2 156.1 56.6 66.3 71.6 106.0 64.7 71.1 47.5 110.2 76.5 90.5 100.1 72.3 67.8 58.9 47.6 35.3 MT-ATP8 "A6L, ATP8, MTATP8" ENSG00000228253 "Mitochondrially encoded ATP synthase membrane subunit 8" P03928 MT 8366-8572 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 959.7" "Cell line enhanced" "Detected in all" "HeLa: 796.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 352.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 352.9" "unprognostic (1.54e-1)" "unprognostic (4.12e-2)" "unprognostic (3.95e-2)" "unprognostic (2.56e-1)" "unprognostic (3.07e-2)" "unprognostic (1.17e-1)" "prognostic favourable (7.56e-5)" "unprognostic (5.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.52e-3)" "unprognostic (8.26e-2)" "unprognostic (1.30e-2)" "unprognostic (1.10e-1)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (2.62e-1)" "unprognostic (1.63e-2)" 257.8 128.5 111.1 33.5 124.1 20.5 31.2 42.1 82.1 14.9 78.9 115.5 23.9 11.6 31.6 14.4 19.9 203.6 108.7 78.8 151.5 165.2 16.9 18.5 88.8 24.3 56.4 22.8 21.1 27.7 44.2 38.7 65.2 25.7 959.7 33.1 91.5 14.2 52.0 19.3 67.4 26.1 23.2 11.8 19.6 15.4 87.7 58.0 352.9 78.1 75.9 79.1 24.2 187.4 69.2 225.8 43.0 246.0 39.3 110.9 394.6 23.3 17.9 31.4 80.3 125.9 480.2 98.5 84.8 322.5 13.9 130.1 28.2 212.2 90.1 363.2 796.3 181.1 44.9 211.5 311.0 84.6 69.0 39.7 34.2 25.5 192.3 152.3 54.9 100.2 123.9 312.0 49.6 49.9 102.3 109.8 101.0 132.1 187.4 71.0 128.4 149.6 138.8 145.8 135.4 444.2 373.1 87.4 193.7 192.5 180.8 103.3 172.9 274.5 86.1 376.2 53.1 352.9 78.1 97.9 49.4 68.6 73.5 87.7 55.9 58.5 47.2 87.3 68.9 79.1 49.0 75.9 68.0 58.0 44.0 24.2 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell line enhanced" "Detected in all" "HeLa: 859.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria Mitochondria "CAB016241: AB_2229888, HPA069328: " "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favourable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 112.7 170.5 232.0 252.3 531.8 243.6 246.0 257.3 85.7 65.0 108.8 205.2 367.8 298.0 123.7 195.5 428.5 26.5 228.0 93.1 140.8 162.5 178.9 859.1 383.8 73.7 103.2 226.6 284.1 237.4 64.2 142.7 78.2 113.5 213.9 192.4 273.1 84.4 462.1 58.9 139.6 110.6 69.3 178.8 329.5 298.3 110.9 147.9 89.2 345.8 160.5 198.4 347.4 311.5 260.6 177.4 255.7 129.0 101.3 97.0 67.6 128.7 272.4 126.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 MT-CO2 "CO2, COX2, MTCO2" ENSG00000198712 "Mitochondrially encoded cytochrome c oxidase II" P00403 MT 7586-8269 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 489.9;skeletal muscle: 343.4" "Cell line enhanced" "Detected in all" "HeLa: 1055.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016243, HPA051505, HPA054758" Enhanced 1300000 "CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (2.77e-2)" "unprognostic (1.96e-2)" "prognostic favourable (2.89e-4)" "unprognostic (1.06e-1)" "unprognostic (3.39e-1)" "unprognostic (2.72e-3)" "prognostic favourable (7.10e-4)" "unprognostic (1.25e-1)" "unprognostic (9.30e-2)" "unprognostic (3.05e-1)" "unprognostic (1.70e-1)" "unprognostic (9.50e-2)" "unprognostic (3.72e-3)" 54.6 64.8 149.7 21.7 194.8 30.2 45.5 48.9 99.5 27.0 106.9 73.6 23.8 46.3 35.8 25.1 23.7 252.1 151.9 112.4 158.4 173.8 22.7 22.8 154.6 21.2 46.4 50.4 22.5 41.4 38.2 106.4 61.7 56.0 343.4 56.4 51.1 40.0 77.8 25.9 68.5 28.2 23.3 29.5 29.9 16.2 379.8 278.1 489.9 409.1 220.4 273.9 181.4 109.3 176.1 234.4 226.5 479.4 184.8 172.7 142.7 115.8 81.1 122.6 189.3 247.3 228.7 119.5 209.8 415.6 31.0 293.5 109.9 177.1 158.8 164.0 1055.8 364.0 104.4 137.9 184.3 271.0 434.3 41.7 149.8 89.8 153.1 223.1 222.2 236.8 100.8 397.3 61.3 112.1 105.4 71.4 191.6 330.8 305.7 87.7 145.1 117.5 289.9 206.1 201.8 559.1 221.4 196.6 170.7 185.4 100.3 113.3 112.7 129.0 104.6 278.6 129.1 489.9 409.1 476.0 194.9 292.9 236.6 379.8 217.1 218.8 205.5 378.1 227.9 273.9 180.3 220.4 308.7 278.1 170.3 181.4 MT-CO3 "CO3, COIII, COX3, MTCO3" ENSG00000198938 "Mitochondrially encoded cytochrome c oxidase III" P00414 MT 9207-9990 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 319.5" "Cell line enhanced" "Detected in all" "HeLa: 798.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042788 Approved "HPA042788: AB_10793985" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.93e-1)" "prognostic favourable (2.01e-4)" "unprognostic (1.18e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-2)" "prognostic favourable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (8.80e-3)" "unprognostic (2.75e-2)" "unprognostic (1.20e-1)" "unprognostic (9.29e-2)" "unprognostic (1.33e-2)" 56.5 83.7 174.1 20.5 149.4 34.8 55.5 47.4 106.2 30.5 90.9 76.1 27.5 46.0 40.4 26.3 28.7 290.4 159.6 111.4 190.3 143.1 21.0 22.8 120.2 27.9 38.9 60.5 26.7 32.5 37.3 95.5 79.0 64.3 319.5 70.0 55.3 39.0 61.9 21.7 60.5 36.5 31.0 31.0 26.9 18.7 247.1 126.7 244.3 245.3 141.7 181.1 106.8 128.9 153.1 235.3 334.1 468.7 193.4 128.7 168.0 99.6 66.4 102.5 204.9 192.7 288.5 72.8 139.5 354.1 37.0 201.8 117.7 97.8 161.8 153.4 798.5 340.3 94.7 91.2 202.1 185.7 287.1 73.0 108.9 122.8 121.5 292.4 219.2 263.4 92.6 532.0 52.2 110.5 99.1 74.2 207.9 413.9 228.0 105.4 146.4 78.3 85.8 162.3 179.3 402.5 196.6 111.4 190.9 207.8 109.6 120.4 77.5 161.1 111.2 297.5 73.1 132.0 245.3 121.5 110.0 128.3 137.4 198.7 119.5 127.0 126.7 247.1 153.2 181.1 244.3 141.7 122.3 107.8 79.5 106.8 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell line enhanced" "Detected in all" "ASC diff: 483.1;HeLa: 486.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400" Enhanced Approved Mitochondria Mitochondria "CAB032215: AB_2261378, HPA068400: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favourable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 72.3 97.8 121.2 129.4 483.1 77.7 97.7 83.4 34.6 21.9 37.9 96.2 160.1 185.5 40.9 98.8 228.2 17.9 102.5 53.7 90.5 80.3 103.6 486.1 171.4 91.1 58.1 126.7 167.8 153.0 41.4 89.2 55.4 52.9 116.7 111.4 199.8 54.0 119.9 26.9 66.4 63.9 47.6 116.1 173.6 169.1 43.2 76.4 58.1 109.9 82.2 160.2 200.7 173.5 76.7 100.4 139.7 64.0 32.1 42.9 79.4 46.1 90.7 48.2 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 MT-ND1 "MTND1, NAD1, ND1" ENSG00000198888 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1" P03886 MT 3307-4262 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 314.4;skeletal muscle: 398.2" "Cell line enhanced" "Detected in all" "HeLa: 660.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 314.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 314.4" "Low region specificity" "Detected in all" CAB033779 Approved "CAB033779: AB_2149736" "prognostic favourable (3.63e-4)" "unprognostic (3.55e-1)" "unprognostic (3.77e-2)" "unprognostic (3.65e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.95e-3)" "unprognostic (5.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.05e-2)" "prognostic favourable (3.26e-4)" "unprognostic (8.67e-2)" "unprognostic (8.66e-2)" "unprognostic (3.24e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-2)" "unprognostic (2.85e-2)" 83.5 48.0 118.0 15.2 136.1 17.7 31.8 45.0 85.9 19.6 58.3 40.2 16.3 43.4 30.7 16.7 17.6 223.1 106.1 74.3 96.0 104.7 20.5 12.1 101.8 14.2 48.2 35.1 14.3 32.2 26.6 58.6 71.2 48.4 398.2 75.4 33.3 24.6 55.2 16.7 45.0 29.8 13.8 17.1 19.9 9.4 60.8 32.2 314.4 54.4 35.8 46.4 19.5 99.9 102.3 83.9 76.4 318.6 58.0 107.9 86.3 25.5 24.0 25.3 177.8 109.1 122.7 54.9 65.0 66.8 9.2 51.9 48.1 87.5 72.1 136.6 660.0 251.9 68.4 64.6 135.0 137.5 142.0 37.1 53.5 25.7 62.8 76.7 71.0 137.5 52.0 267.8 22.5 77.1 54.8 38.1 65.9 132.8 162.3 34.9 55.6 47.8 76.6 83.7 68.3 224.3 135.2 80.2 72.5 102.2 71.6 85.2 52.5 56.8 53.9 114.6 21.9 314.4 54.4 103.0 25.7 31.4 37.3 54.3 30.8 34.0 20.6 60.8 41.1 46.4 157.8 35.8 32.0 32.2 22.0 19.5 MT-ND2 "MTND2, NAD2, ND2" ENSG00000198763 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2" P03891 MT 4470-5511 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 432.3" "Cell line enhanced" "Detected in all" "HeLa: 601.0" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "basophil: 432.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 432.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.53e-2)" "unprognostic (1.36e-1)" "unprognostic (4.77e-1)" "unprognostic (4.79e-2)" "unprognostic (9.56e-3)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (3.38e-3)" "unprognostic (4.55e-3)" "unprognostic (3.79e-2)" "unprognostic (4.35e-2)" "unprognostic (3.94e-2)" "unprognostic (2.11e-1)" "unprognostic (5.92e-2)" "unprognostic (4.35e-2)" 93.0 57.2 116.0 16.9 169.9 15.6 33.9 40.1 73.5 22.6 53.7 50.1 21.5 59.8 29.0 22.1 19.3 262.4 112.2 85.2 125.9 128.9 20.9 14.7 113.0 25.1 62.0 24.3 20.3 37.0 28.1 59.0 85.3 41.0 263.4 72.7 39.2 24.6 72.4 15.2 49.2 27.3 18.2 17.7 23.8 13.1 66.1 43.5 432.3 54.8 43.0 57.9 21.8 92.8 102.3 91.6 154.4 330.8 59.0 86.6 86.7 21.7 23.2 29.3 128.7 125.5 133.3 82.5 62.2 166.7 14.4 108.4 50.2 116.0 74.5 153.8 601.0 207.5 67.8 149.2 179.0 97.6 198.2 57.0 56.5 34.0 112.1 130.7 55.7 109.8 84.6 241.4 45.9 67.0 74.4 51.3 111.8 171.8 143.7 57.3 68.7 37.5 115.2 138.2 177.3 172.5 107.5 87.2 108.0 122.6 109.8 85.5 73.2 112.2 56.6 128.8 39.0 432.3 54.8 93.1 34.1 39.7 54.7 58.6 39.5 42.5 23.0 66.1 48.5 57.9 88.6 43.0 45.7 43.5 25.9 21.8 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell line enhanced" "Detected in all" "ASC diff: 639.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Approved Cytosol Cytosol "HPA063296: " "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favourable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 84.7 138.5 92.5 90.7 639.2 128.1 77.0 71.4 42.0 38.8 43.9 208.4 132.2 88.4 111.0 91.8 176.8 39.7 156.2 66.7 126.6 190.5 86.9 461.1 343.0 99.8 127.8 131.5 221.5 289.5 64.9 73.3 60.3 68.4 103.3 73.1 277.1 67.1 170.7 47.5 128.2 58.2 90.9 81.3 235.9 234.2 38.1 82.9 34.5 69.2 141.3 160.1 206.6 102.3 60.0 91.1 104.2 76.4 40.2 52.6 190.4 48.7 77.7 34.0 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 392.9" "Cell line enhanced" "Detected in all" "HeLa: 810.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053928 Approved "HPA053928: " "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favourable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 82.5 72.4 124.2 19.8 138.2 14.9 34.5 43.8 78.5 34.1 68.7 56.5 27.8 37.1 32.9 25.2 23.7 292.7 122.4 90.3 129.8 178.5 20.8 17.4 101.6 25.5 58.3 37.8 19.7 39.1 37.3 82.1 61.7 65.6 288.4 61.1 41.0 37.8 63.6 21.7 67.7 29.6 24.3 23.4 26.0 15.3 164.7 87.6 392.9 119.5 87.1 129.7 53.0 101.4 105.5 137.2 202.5 322.5 81.3 96.1 103.3 39.6 24.0 46.9 160.1 116.2 180.6 91.2 88.0 190.1 12.2 167.3 43.1 104.2 66.4 111.2 810.9 268.4 48.7 111.7 132.3 137.5 177.3 35.3 126.8 58.0 92.6 223.7 86.4 228.8 44.0 253.9 38.8 71.8 59.8 43.1 108.9 175.6 219.4 50.6 68.5 60.1 199.9 103.3 139.9 264.1 160.8 98.3 95.6 131.5 80.0 134.2 54.4 80.4 64.1 194.2 52.2 392.9 119.5 268.8 82.9 91.3 115.5 148.0 93.0 98.9 65.9 164.7 109.6 129.7 105.7 87.1 89.0 87.6 67.6 53.0 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Cell line enhanced" "Detected in all" "HeLa: 879.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075648 Approved Mitochondria Mitochondria "HPA075648: " "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favourable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 96.4 89.7 161.9 164.8 567.3 119.4 71.4 207.0 51.9 32.5 59.4 149.1 89.1 239.3 84.9 139.8 183.9 25.1 221.6 64.7 94.2 103.6 172.0 879.2 276.9 83.3 176.8 154.7 209.0 227.1 61.9 216.8 65.0 94.8 171.6 119.0 172.3 67.2 226.9 40.8 108.4 39.0 69.8 106.4 172.8 203.7 49.1 66.5 101.6 160.9 69.4 114.4 222.6 207.8 85.3 106.2 124.8 79.2 155.3 72.7 127.4 61.2 240.6 39.8 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 MT-ND5 "MTND5, NAD5, ND5" ENSG00000198786 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5" P03915 MT 12337-14148 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2" "Cell line enhanced" "Detected in all" "HeLa: 362.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.87e-1)" "unprognostic (3.18e-2)" "unprognostic (3.00e-1)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (5.09e-3)" "unprognostic (1.06e-2)" "unprognostic (3.01e-1)" "unprognostic (3.29e-3)" "unprognostic (4.78e-2)" "prognostic favourable (7.31e-5)" "unprognostic (9.93e-3)" "unprognostic (8.75e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" 47.2 30.4 71.2 14.8 94.5 11.3 16.5 23.2 45.8 13.6 30.3 38.9 16.6 24.9 26.2 21.4 19.1 190.3 65.0 52.8 56.3 66.6 19.3 9.4 56.1 18.6 22.9 23.1 7.9 15.1 27.5 28.0 25.7 21.5 223.2 63.9 29.5 25.3 37.9 12.6 41.4 14.6 12.8 13.2 24.9 8.0 124.1 89.3 193.9 123.4 79.6 99.3 33.7 69.1 73.7 90.2 87.1 272.5 71.4 48.6 142.1 21.8 15.9 26.7 108.2 91.2 168.2 72.1 66.3 148.5 8.4 74.6 26.6 94.1 57.4 123.2 362.2 182.8 31.4 86.1 128.3 106.6 59.7 18.1 43.4 32.1 44.8 80.5 54.4 131.1 32.2 106.4 17.8 40.4 61.9 42.3 72.1 96.6 137.8 27.0 41.2 66.2 118.6 39.5 86.3 129.4 224.8 92.1 64.2 108.4 55.0 30.7 53.1 46.9 49.2 78.7 40.0 193.9 123.4 79.9 81.3 100.2 99.3 99.4 79.3 87.3 73.4 124.1 78.5 86.6 45.3 79.6 95.9 89.3 62.1 33.7 MT-ND6 "MTND6, NAD6, ND6" ENSG00000198695 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6" P03923 MT 14149-14673 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 395.3;skeletal muscle: 593.2" "Cell line enhanced" "Detected in many" "HeLa: 514.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.96e-1)" "unprognostic (3.27e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.03e-3)" "unprognostic (6.02e-3)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (6.06e-3)" "unprognostic (2.91e-1)" "prognostic favourable (8.91e-6)" "unprognostic (3.64e-2)" "unprognostic (1.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.92e-2)" 79.2 43.1 55.5 34.4 78.5 30.7 9.6 14.7 76.1 5.9 30.2 90.3 19.2 0.0 69.5 23.2 40.2 395.3 50.7 41.2 65.5 42.8 28.5 25.9 41.9 23.2 48.0 0.0 3.5 10.3 28.0 0.3 48.1 0.0 593.2 176.3 63.8 0.0 24.8 19.9 53.2 22.7 17.5 0.0 32.3 5.7 127.3 91.2 164.8 108.2 88.8 104.3 29.7 97.5 79.2 70.1 88.9 11.8 1.1 50.3 131.9 0.2 0.4 0.4 107.6 99.0 210.5 89.8 3.5 146.0 0.7 2.4 0.7 124.3 60.8 126.1 514.1 307.3 0.9 79.8 119.1 2.0 3.2 3.2 2.7 0.7 54.2 82.7 2.9 208.4 24.5 110.1 15.2 38.9 59.6 44.8 90.4 1.9 287.8 28.9 46.4 68.7 121.0 54.5 93.7 155.6 268.3 77.9 65.8 110.3 52.8 28.3 75.5 50.5 52.9 81.4 45.2 164.8 108.2 68.3 89.1 103.5 104.3 118.4 94.5 96.1 66.2 127.3 94.7 102.4 53.7 88.8 103.7 91.2 71.8 29.7 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA029768: , HPA054359: " "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favourable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 34.5 37.3 26.7 28.4 32.2 20.4 33.4 27.3 24.9 19.2 23.9 20.8 28.9 28.1 42.1 28.5 33.4 37.4 26.2 22.0 38.9 51.7 29.2 68.1 46.7 25.0 44.6 32.5 33.2 35.7 20.4 15.9 23.8 15.8 43.8 26.3 61.1 31.7 42.3 39.4 66.7 32.1 25.4 84.6 57.8 49.2 19.5 25.7 56.1 69.6 37.4 17.6 52.6 30.6 16.4 16.6 34.0 53.2 40.4 50.0 36.8 29.7 53.0 20.2 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025402 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" 12000 Mitochondria "CAB070846: AB_11152346, HPA059529: , HPA067045: " "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favourable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 19.0 37.5 19.7 18.2 30.4 20.3 19.5 26.2 31.5 14.5 31.0 24.5 18.6 30.4 14.8 18.4 28.5 18.8 17.1 66.0 28.6 18.7 36.3 40.6 13.1 13.8 21.4 27.7 19.8 23.5 25.1 15.5 15.9 33.4 13.7 34.7 16.2 20.6 26.7 67.0 26.1 24.3 18.6 27.0 13.8 24.9 15.4 19.8 13.2 16.9 34.1 20.2 19.3 17.7 24.6 35.7 11.0 27.7 21.2 24.6 24.5 16.8 16.6 12.3 20.7 14.9 24.8 20.2 14.3 18.5 20.7 20.8 16.5 21.1 12.5 6.6 15.9 22.6 27.8 25.7 26.5 16.6 18.4 16.4 15.6 35.3 22.5 22.4 13.3 24.1 21.0 16.5 22.6 26.2 24.9 8.8 22.1 25.8 21.2 23.0 14.5 18.0 21.7 27.5 21.9 29.3 33.1 19.5 12.8 14.1 32.0 22.3 29.8 22.7 16.3 14.8 15.0 18.7 15.9 15.2 6.8 19.9 16.0 20.5 17.6 6.3 26.1 11.0 18.9 27.7 24.6 24.6 19.1 20.5 35.7 18.3 19.0 19.0 5.8 21.2 23.4 12.7 22.0 24.5 19.7 30.4 26.2 31.5 28.6 18.7 21.4 27.7 33.4 19.8 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA072209 Uncertain Mitochondria Mitochondria "HPA072209: " "unprognostic (2.24e-1)" "prognostic favourable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favourable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 32.3 70.8 50.2 40.9 41.3 43.4 49.3 29.9 75.2 35.3 45.1 25.8 41.2 41.6 35.9 36.9 53.1 38.4 41.4 149.3 41.9 45.8 44.1 59.8 37.9 51.9 48.3 45.8 38.4 70.9 13.5 33.8 32.5 35.9 35.1 19.6 35.9 76.3 41.1 106.0 32.4 39.5 45.2 40.2 31.5 38.8 21.2 27.0 37.3 37.8 72.1 30.5 38.3 37.2 63.3 90.2 54.3 87.4 44.8 73.7 121.4 49.1 38.1 28.4 46.1 23.3 37.9 31.8 34.0 39.3 62.4 57.7 45.4 26.2 48.7 53.8 32.4 32.6 19.5 39.7 15.1 41.9 73.4 20.0 36.6 72.6 60.9 29.7 29.7 51.8 36.1 35.4 16.8 40.7 42.1 54.2 31.4 37.5 77.0 53.0 42.9 95.8 53.4 35.5 69.6 38.5 32.9 41.1 43.7 26.5 43.5 59.9 33.5 63.4 36.4 34.8 33.5 69.3 55.6 82.5 71.5 63.0 58.8 71.3 44.7 54.3 87.4 47.7 53.5 68.0 54.8 63.3 59.6 54.0 74.9 54.6 56.7 49.5 39.2 44.8 57.7 90.2 73.7 121.4 50.2 41.3 29.9 75.2 41.9 45.8 48.3 45.8 35.9 27.0 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria Mitochondria "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 40.9 44.6 37.3 26.5 30.6 28.5 27.7 19.6 28.8 42.8 38.8 55.0 21.2 47.2 11.6 29.9 31.0 38.3 45.2 48.6 40.6 46.0 39.4 37.2 55.4 31.5 55.9 48.2 30.6 57.1 35.9 44.0 35.0 36.8 21.9 41.4 59.5 38.7 86.5 28.3 77.6 29.6 32.3 53.8 41.9 61.6 35.5 21.5 33.2 48.4 25.4 47.8 36.9 40.0 22.7 23.1 33.0 33.3 35.9 53.2 72.0 13.6 46.8 34.7 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.7 24.9 46.0 45.8 47.0 38.2 43.2 40.2 44.5 45.3 44.3 40.3 50.7 44.9 94.6 48.5 27.4 32.6 43.6 18.7 27.4 73.7 34.3 39.7 49.4 42.1 64.4 48.4 51.2 39.7 31.8 36.7 32.6 37.8 64.3 36.0 67.1 76.4 64.0 46.9 69.4 43.9 29.9 68.6 66.1 48.5 43.8 55.4 40.9 48.2 40.0 29.8 88.7 33.9 44.5 15.1 51.8 49.9 45.8 36.0 48.3 39.2 50.0 32.4 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 NDUFA2 B8 ENSG00000131495 "NADH:ubiquinone oxidoreductase subunit A2" O43678 5 140638740-140647785 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035933 Uncertain 12000 "HPA035933: AB_10669661" "unprognostic (4.48e-1)" "prognostic favourable (6.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.96e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-3)" "unprognostic (4.01e-1)" "unprognostic (2.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.39e-3)" "unprognostic (1.84e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.78e-2)" "unprognostic (9.96e-2)" "unprognostic (4.22e-1)" "unprognostic (1.30e-3)" 25.6 41.5 37.1 19.2 35.1 31.1 23.1 20.8 31.0 18.0 29.1 13.1 33.9 34.2 12.8 28.1 22.8 18.2 29.8 55.8 30.3 30.5 41.4 44.8 19.7 23.5 35.6 22.1 17.6 40.8 9.0 23.1 21.2 24.1 20.2 21.4 18.1 39.6 37.4 90.9 13.5 30.9 18.9 25.5 22.1 24.2 21.4 21.7 22.0 26.9 46.7 17.2 17.5 15.7 47.0 64.1 66.6 66.9 31.3 48.7 63.1 24.6 36.0 17.7 36.4 20.7 15.3 23.3 14.8 12.4 17.9 22.2 55.1 28.0 22.7 36.1 11.8 19.3 16.0 27.4 10.5 22.7 42.3 14.7 34.3 42.2 12.6 25.9 19.2 18.4 20.4 11.9 8.5 18.4 15.2 36.6 16.4 34.8 35.1 51.9 18.6 36.1 27.4 21.8 39.2 29.3 25.6 22.7 20.0 20.4 52.4 39.3 49.1 40.1 13.5 21.4 16.6 18.6 23.0 41.2 59.5 33.6 25.3 28.9 12.6 33.8 66.9 66.6 33.3 56.8 34.2 47.0 36.7 36.8 55.9 40.0 34.0 35.5 60.0 31.3 44.8 64.1 48.7 63.1 37.1 35.1 20.8 31.0 30.3 30.5 35.6 22.1 24.1 21.7 NDUFA3 B9 ENSG00000170906 "NADH:ubiquinone oxidoreductase subunit A3" O95167 19 54102728-54109257 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046976 Supported "HPA046976: AB_10960994" "unprognostic (3.04e-2)" "unprognostic (4.12e-3)" "unprognostic (9.53e-2)" "unprognostic (5.95e-2)" "unprognostic (6.73e-2)" "unprognostic (3.14e-2)" "unprognostic (3.91e-1)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.00e-2)" "prognostic favourable (9.65e-4)" "unprognostic (9.91e-2)" "unprognostic (3.24e-3)" "unprognostic (7.79e-2)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" "prognostic favourable (4.80e-4)" 17.7 20.8 47.4 15.4 50.9 21.8 22.0 17.3 36.5 12.8 22.6 13.7 21.5 31.8 11.7 25.1 15.8 17.1 20.0 66.1 40.9 33.1 29.7 37.2 20.8 26.9 43.3 31.1 12.9 34.0 22.2 25.5 12.3 29.5 15.9 25.8 13.9 27.0 24.7 95.7 42.4 27.6 15.7 26.8 14.7 23.7 32.6 19.6 16.1 19.5 34.7 16.6 16.3 15.1 20.9 27.3 21.7 16.7 17.1 16.4 18.8 6.6 5.8 5.8 8.0 7.7 7.1 4.6 5.7 6.3 4.6 5.2 7.4 4.9 5.3 3.9 5.0 4.2 4.6 11.0 2.1 8.0 24.2 5.9 7.8 8.2 5.5 6.6 2.4 4.5 10.9 4.0 5.3 8.3 3.2 3.8 4.7 21.5 6.1 7.7 4.9 11.2 2.7 3.1 11.2 3.4 16.8 9.6 5.1 5.3 12.8 3.1 14.9 6.5 7.4 6.1 3.0 2.6 9.3 5.9 4.4 3.1 6.7 6.2 2.9 17.2 16.3 21.7 15.0 16.7 15.0 20.9 15.5 15.6 15.8 19.8 16.3 16.4 15.9 17.1 13.7 27.3 15.4 18.8 47.4 50.9 17.3 36.5 40.9 33.1 43.3 31.1 29.5 19.6 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Supported Mitochondria 18000 Mitochondria "HPA055323: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favourable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 12.6 21.8 37.2 42.7 21.1 19.8 17.1 16.1 15.3 15.1 13.3 27.3 34.8 24.7 15.3 23.1 22.4 24.7 19.1 16.5 12.2 18.0 20.7 25.6 25.4 18.4 28.5 20.4 21.3 19.3 18.5 16.4 21.0 30.7 33.6 31.5 24.4 12.7 25.1 40.7 44.2 17.3 26.5 27.7 38.3 27.5 23.3 24.2 25.5 73.5 14.5 46.4 35.0 18.3 18.1 24.9 25.9 26.5 20.4 26.1 28.3 24.9 30.9 56.0 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Cell line enriched" "Detected in many" 7 "AN3-CA: 54.1" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Approved Mitochondria Mitochondria "HPA055323: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 54.1 2.2 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.1 2.3 0.8 0.4 0.3 0.4 0.0 1.1 0.1 0.2 0.1 0.0 7.8 1.6 0.8 5.0 1.0 0.1 1.9 0.0 0.2 2.9 0.1 1.0 0.4 0.0 0.1 0.9 0.8 0.4 4.1 0.0 0.0 2.9 1.0 0.1 0.1 1.8 0.6 5.7 0.2 0.5 0.0 0.4 0.2 4.1 1.3 0.9 2.0 3.8 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 NDUFA5 "B13, CI-13kB, CI-13KD-B, NUFM, UQOR13" ENSG00000128609 "NADH:ubiquinone oxidoreductase subunit A5" Q16718 7 123536997-123558255 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043175 Supported 69000 "HPA043175: AB_10793992" "prognostic favourable (8.47e-5)" "unprognostic (4.00e-2)" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "unprognostic (4.90e-2)" "unprognostic (3.26e-1)" "unprognostic (2.23e-1)" "unprognostic (3.46e-2)" "unprognostic (1.81e-1)" "unprognostic (2.14e-2)" "unprognostic (1.37e-1)" "unprognostic (9.20e-2)" "prognostic favourable (3.99e-9)" "unprognostic (3.39e-1)" "unprognostic (1.59e-1)" "unprognostic (1.93e-1)" "unprognostic (2.73e-3)" 13.9 39.9 50.4 9.5 47.5 9.5 22.1 30.3 56.3 16.9 22.2 9.9 17.9 22.3 15.7 22.7 16.5 16.5 14.7 64.9 53.9 41.5 53.6 33.6 13.4 10.7 42.6 37.8 14.3 12.2 32.5 31.0 12.7 42.1 23.4 23.7 13.4 22.3 20.6 67.2 9.1 20.7 18.4 29.3 10.6 21.6 13.2 16.0 9.7 43.1 30.4 12.7 16.8 10.8 22.9 18.2 21.3 22.3 24.2 27.0 26.4 11.9 6.8 15.5 19.7 15.4 16.2 8.0 10.2 14.9 11.5 15.5 7.0 16.2 21.7 10.7 12.5 14.0 18.0 16.0 18.1 15.8 12.4 12.3 13.8 14.3 15.4 28.2 13.9 13.3 16.6 9.9 10.8 16.7 42.7 27.2 20.6 7.0 27.4 39.2 23.6 17.4 15.2 16.3 35.5 30.7 10.9 35.4 19.9 14.7 74.7 19.0 17.2 24.0 9.7 15.6 6.1 68.0 17.1 23.0 17.6 22.3 31.9 23.8 20.0 21.3 11.7 12.8 18.7 20.0 27.0 22.9 23.8 20.7 15.2 17.7 26.0 26.2 4.0 24.2 22.3 18.2 23.7 26.4 50.4 47.5 30.3 56.3 53.9 41.5 42.6 37.8 42.1 16.0 NDUFA6 "B14, CI-B14, LYRM6, NADHB14" ENSG00000184983 "NADH:ubiquinone oxidoreductase subunit A6" P56556 22 42085525-42090955 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.48e-2)" "prognostic favourable (3.87e-4)" "unprognostic (7.00e-3)" "prognostic favourable (4.96e-4)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (4.02e-2)" "unprognostic (2.71e-2)" "unprognostic (1.47e-2)" "unprognostic (8.28e-2)" "unprognostic (3.61e-1)" "prognostic favourable (1.05e-6)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (9.49e-2)" "unprognostic (4.84e-2)" 11.1 18.3 18.4 11.6 18.9 16.9 17.3 16.4 17.7 7.8 21.8 8.7 15.7 11.4 10.2 12.7 20.0 8.0 13.3 68.5 14.7 15.3 30.8 39.1 11.5 13.0 18.8 15.0 8.5 17.3 35.1 13.3 22.0 16.2 15.4 30.8 13.2 16.0 15.1 55.8 11.2 25.8 13.8 11.4 11.4 18.9 8.7 9.3 14.0 15.0 34.2 12.9 19.4 10.2 22.6 34.9 26.9 28.3 19.5 25.7 34.8 7.1 0.8 1.9 7.6 15.5 11.6 4.1 0.1 0.1 0.3 0.4 7.5 13.9 0.2 0.7 11.9 8.3 0.5 0.5 1.8 0.1 0.3 0.4 3.8 26.0 0.4 12.9 12.6 6.9 8.3 9.9 15.4 6.3 11.5 13.9 0.6 13.9 7.2 1.5 6.8 21.8 11.6 7.2 0.1 0.6 2.7 0.4 4.9 13.7 9.4 23.4 15.9 0.2 0.0 1.0 17.8 7.8 12.1 8.3 11.2 1.6 5.5 14.8 15.8 19.3 27.2 26.9 19.5 26.6 19.6 22.6 25.7 17.3 34.9 20.3 20.5 22.6 9.4 19.5 28.3 23.0 25.6 34.8 18.4 18.9 16.4 17.7 14.7 15.3 18.8 15.0 16.2 9.3 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favourable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 19.4 36.0 23.9 31.4 25.8 23.7 29.6 22.6 26.9 31.1 26.2 45.6 19.4 28.4 22.4 26.4 48.9 45.2 48.9 30.6 27.8 31.3 22.4 60.4 39.3 27.8 39.5 23.1 25.9 47.9 31.1 20.0 44.6 34.1 21.4 35.4 49.4 24.5 25.7 21.8 69.3 19.6 37.7 41.4 44.7 27.0 41.4 16.3 35.6 42.3 28.1 44.8 19.1 28.9 17.3 17.4 32.4 25.3 24.2 39.0 28.1 36.0 25.6 28.5 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA042268: AB_2677922, HPA073212: " "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favourable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.7 19.5 9.6 12.7 7.1 7.1 27.9 8.3 8.4 16.0 12.2 42.2 21.7 12.2 4.4 8.9 18.2 13.9 12.2 10.5 23.6 24.4 11.9 20.7 31.9 15.6 17.4 12.9 9.0 11.9 10.9 14.9 12.0 8.3 23.1 11.8 20.9 17.3 20.0 24.8 16.2 24.5 14.2 12.7 22.0 24.7 7.0 7.8 10.4 28.1 14.5 5.8 16.6 8.4 12.2 24.8 11.1 19.1 4.5 5.3 20.1 12.7 10.8 13.3 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054364 Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA054364: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favourable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 27.7 20.5 25.7 22.9 18.3 19.9 35.8 21.4 15.9 21.6 17.8 17.8 22.6 46.0 35.2 15.4 23.0 44.7 25.4 17.1 26.0 51.6 24.7 36.8 87.3 19.2 45.7 20.5 18.4 35.4 15.9 17.2 27.4 51.6 23.4 23.3 42.0 35.4 69.6 66.8 47.7 48.7 28.9 62.5 19.8 25.0 35.4 27.6 23.9 43.9 40.0 35.4 38.3 21.5 19.8 20.9 19.2 29.3 29.9 43.4 51.5 22.2 37.1 22.4 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "HPA063737: " "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favourable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.9 56.7 46.1 29.7 30.2 22.6 21.1 34.5 19.4 20.5 19.0 34.1 47.6 25.3 32.1 19.3 35.0 26.3 28.0 18.5 39.7 60.3 48.9 89.0 40.7 24.0 38.6 28.0 27.8 17.0 21.4 19.0 18.2 26.5 52.0 28.0 105.8 38.1 34.6 23.3 69.5 34.1 43.8 37.5 51.0 69.3 30.8 22.4 67.6 41.1 43.8 61.6 60.4 40.7 13.0 24.8 26.1 23.0 41.1 64.2 56.1 39.3 28.6 26.9 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 NDUFB10 PDSW ENSG00000140990 "NADH:ubiquinone oxidoreductase subunit B10" O96000 16 1959508-1961975 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 280.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073189 Supported "HPA073189: " "unprognostic (3.56e-1)" "prognostic favourable (7.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (7.84e-2)" "unprognostic (1.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.44e-1)" "prognostic favourable (9.43e-6)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (4.43e-1)" "unprognostic (8.76e-2)" 21.6 20.3 29.0 18.3 30.9 15.6 23.5 21.0 32.2 18.2 31.3 17.0 22.2 32.3 18.8 22.9 22.1 18.9 22.0 97.1 26.9 20.1 28.8 33.9 13.0 22.3 27.7 28.7 15.4 29.8 26.3 13.3 15.1 20.1 18.9 28.2 17.9 32.0 24.2 280.4 16.8 27.8 27.5 18.9 15.7 25.2 19.2 15.6 16.6 20.0 73.7 17.3 20.1 17.7 64.6 84.7 66.6 75.5 51.8 84.8 80.2 17.3 51.0 24.5 29.3 24.7 23.5 25.3 21.6 26.2 25.1 17.3 37.5 23.5 35.4 37.0 27.7 37.0 27.0 33.0 19.0 32.4 100.4 27.3 40.3 42.5 31.7 43.9 26.4 26.4 29.9 24.2 27.2 29.0 25.4 34.7 31.9 72.3 51.8 45.9 31.5 58.2 61.2 26.2 75.7 36.5 17.9 55.6 35.7 40.6 66.2 28.4 40.2 29.9 24.9 23.5 22.1 33.3 23.5 57.5 44.2 46.2 16.5 22.0 24.5 54.8 75.5 66.6 57.7 63.2 55.8 64.6 71.2 72.1 79.0 58.0 56.9 59.5 41.3 51.8 53.2 84.7 84.8 80.2 29.0 30.9 21.0 32.2 26.9 20.1 27.7 28.7 20.1 15.6 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.5 29.1 23.0 26.6 19.9 17.1 24.5 14.3 16.6 23.4 22.7 31.0 24.0 24.1 12.3 15.5 25.1 25.9 15.1 15.6 23.3 69.2 13.8 39.8 25.6 20.0 23.1 21.3 18.7 13.9 20.2 13.4 17.4 16.5 31.8 13.1 44.2 27.2 64.1 36.0 53.6 29.7 22.8 54.8 23.7 20.9 42.5 31.4 27.1 31.2 21.5 44.8 30.4 13.2 16.4 22.3 30.4 16.6 31.4 27.4 27.0 17.8 14.5 21.8 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051377: " "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favourable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.1 24.0 52.4 38.7 39.3 34.9 30.0 26.2 31.1 29.6 51.8 41.2 31.4 44.9 36.2 20.4 21.4 42.1 24.7 52.3 73.7 23.0 57.3 58.2 30.6 35.3 30.9 43.6 36.5 29.5 18.1 46.1 38.7 37.9 42.9 122.1 55.4 91.2 55.7 76.7 31.9 23.4 72.2 62.2 81.9 48.9 48.3 41.0 67.2 35.9 29.2 40.5 38.5 41.0 24.2 48.4 51.5 36.2 67.3 54.9 62.5 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Approved "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 16.9 19.9 23.4 13.9 23.6 10.1 14.7 13.5 33.3 10.4 27.1 8.2 16.8 23.8 8.4 18.9 21.1 8.6 13.0 57.5 24.2 19.9 35.2 25.8 10.4 12.6 25.6 29.7 6.8 13.0 15.3 13.2 10.9 20.8 11.7 23.8 8.8 21.8 11.7 113.9 8.6 21.2 10.8 19.2 13.4 17.5 17.2 17.8 10.8 11.6 39.1 16.9 9.4 12.0 40.5 55.8 66.2 52.9 36.4 47.3 27.2 24.8 20.3 30.7 17.4 26.3 22.6 26.4 29.0 18.3 21.4 23.5 45.5 30.8 17.9 36.0 23.7 23.5 25.0 35.3 32.7 36.8 58.7 41.5 49.2 53.6 16.9 59.8 24.3 22.0 26.7 25.0 14.9 27.5 37.8 35.3 33.8 28.9 42.8 66.4 20.5 67.4 31.3 25.5 55.1 45.6 37.9 30.7 22.3 22.1 23.4 36.3 21.8 53.3 27.6 20.6 27.4 21.7 31.1 27.0 53.5 60.6 37.2 35.1 23.8 43.5 37.7 40.0 32.7 51.7 36.3 40.5 38.5 37.8 45.8 31.4 33.8 41.2 66.2 36.4 52.9 55.8 47.3 27.2 23.4 23.6 13.5 33.3 24.2 19.9 25.6 29.7 20.8 17.8 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051739 Enhanced Supported "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA051739: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favourable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.9 37.9 45.3 45.4 28.7 34.2 36.9 29.2 38.8 38.0 42.0 36.8 39.9 26.4 59.3 32.7 50.3 34.9 37.2 28.7 40.4 40.3 40.8 39.8 37.0 17.4 35.8 48.3 30.8 49.7 18.5 24.4 47.4 24.1 40.6 40.8 40.7 70.8 51.9 36.1 103.9 41.0 25.9 58.0 61.6 32.5 51.1 52.4 34.2 38.4 62.2 64.7 57.2 36.3 33.7 44.3 14.2 40.7 50.2 45.2 79.8 53.1 50.4 45.5 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favourable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.2 6.5 16.3 19.7 21.5 29.0 22.1 14.8 18.7 21.2 21.4 19.6 17.0 20.4 44.9 12.5 25.8 17.6 19.6 21.4 42.1 14.7 21.9 11.9 16.3 19.8 26.1 17.4 26.7 25.4 11.9 19.9 24.3 18.4 29.7 22.7 16.6 15.0 20.3 23.5 26.5 16.7 18.9 63.1 38.3 18.0 11.6 19.5 9.0 50.6 34.9 77.1 42.6 15.6 14.0 13.3 19.1 35.2 39.5 40.9 30.1 22.6 28.0 19.9 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria Mitochondria "HPA044001: AB_10959448, HPA053334: " "unprognostic (4.09e-1)" "prognostic favourable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favourable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 29.8 18.4 20.5 23.4 13.9 13.0 13.1 20.0 16.4 18.5 20.5 18.0 13.5 22.3 20.9 13.8 17.0 19.3 22.1 14.0 30.6 30.9 53.0 28.2 18.5 13.6 26.4 13.7 13.4 10.8 16.7 12.7 16.7 16.9 25.2 20.7 17.3 35.5 62.4 21.6 40.9 24.5 17.2 20.6 20.7 11.3 20.6 23.3 23.2 26.7 13.5 25.2 20.5 14.8 20.3 30.7 22.3 29.4 11.2 21.0 36.2 33.9 18.6 9.5 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 NDUFB7 "B18, CI-B18, MGC2480" ENSG00000099795 "NADH:ubiquinone oxidoreductase subunit B7" P17568 19 14566078-14572062 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 182.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002817 Approved "HPA002817: AB_1079462" "unprognostic (2.80e-2)" "prognostic favourable (3.54e-4)" "unprognostic (2.03e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.95e-1)" "unprognostic (1.45e-3)" "unprognostic (2.07e-1)" "unprognostic (1.87e-2)" "unprognostic (2.02e-2)" "unprognostic (4.14e-2)" "prognostic favourable (2.41e-4)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (9.25e-3)" 35.5 34.0 42.1 24.1 37.3 26.0 34.6 25.1 50.3 24.7 36.2 19.4 28.5 36.6 22.2 31.6 28.3 27.2 31.9 110.4 32.6 32.3 36.2 44.9 22.6 26.8 40.7 29.6 21.3 55.1 20.4 23.9 21.8 29.3 24.5 17.0 24.9 58.1 30.8 182.0 22.6 32.7 28.7 26.4 18.9 30.3 20.9 20.0 20.4 27.6 65.5 19.7 19.3 23.6 64.2 82.6 48.7 77.5 67.3 83.1 90.6 36.8 37.2 15.1 32.1 13.1 13.2 26.8 17.2 19.3 32.2 30.6 49.4 20.5 16.8 51.8 16.0 28.9 9.9 37.7 4.3 25.9 50.7 32.5 61.3 51.0 23.3 21.0 22.6 21.5 31.5 16.9 8.0 25.7 20.0 30.9 14.8 69.8 34.1 46.9 38.4 122.3 26.7 18.0 40.7 22.5 39.5 32.8 34.9 18.0 42.1 45.8 27.7 37.9 19.0 41.0 19.9 51.7 31.6 42.3 43.3 21.0 39.4 41.0 27.4 48.7 77.5 23.8 83.1 68.5 77.1 64.2 56.8 70.0 74.7 56.9 47.6 62.2 21.9 67.3 64.7 82.6 63.8 90.6 42.1 37.3 25.1 50.3 32.6 32.3 40.7 29.6 29.3 20.0 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003886 Supported Approved Mitochondria Mitochondria "HPA003886: AB_1079463" "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 35.2 39.8 86.7 27.0 67.4 35.6 26.1 39.3 81.5 25.4 37.7 23.8 23.1 38.8 24.7 42.3 36.8 28.8 28.2 110.0 70.6 62.8 50.4 50.6 19.8 28.1 63.9 54.1 27.7 36.3 31.5 31.4 19.9 49.9 26.6 36.2 25.7 39.7 34.5 88.5 24.3 33.8 41.5 38.9 22.1 31.5 12.0 41.4 18.3 28.3 49.2 27.8 25.2 21.5 76.6 88.6 62.2 74.4 60.5 105.9 129.7 41.8 70.6 38.2 67.7 28.9 28.1 42.2 28.6 62.2 44.0 47.7 95.7 48.8 44.4 25.8 32.0 50.2 28.5 46.5 35.0 29.1 72.9 31.2 59.9 77.4 39.2 63.7 53.8 34.6 42.0 43.9 59.2 48.1 32.4 28.2 37.8 50.8 61.4 80.2 25.5 65.9 42.9 41.7 58.5 51.5 47.9 26.4 37.1 21.0 40.2 41.5 59.7 57.1 32.2 25.2 28.5 26.8 50.0 51.2 46.5 55.1 50.0 67.5 28.0 35.1 74.4 62.2 59.0 72.9 69.5 76.6 73.6 67.8 80.4 64.1 79.8 76.7 17.1 60.5 61.4 88.6 105.9 129.7 86.7 67.4 39.3 81.5 70.6 62.8 63.9 54.1 49.9 41.4 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favourable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.4 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 32.9 29.7 22.6 24.5 33.2 40.5 69.6 19.0 42.0 28.5 21.6 19.0 21.2 33.0 23.7 51.4 23.5 43.0 24.1 20.7 90.2 34.0 43.3 20.6 59.4 23.0 15.6 39.0 34.1 24.4 28.6 22.4 30.9 254.7 30.4 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044556 Approved Supported Mitochondria Mitochondria "HPA044556: AB_10794402" "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favourable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favourable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favourable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.6 3.6 10.6 13.1 7.6 8.3 8.4 10.7 7.1 7.9 6.0 6.4 10.8 3.8 3.9 7.5 5.1 20.6 7.0 6.3 5.4 6.6 6.0 7.1 10.2 9.5 5.0 3.3 11.9 10.5 7.5 11.1 7.8 13.8 16.2 5.4 6.1 7.3 12.3 8.1 4.9 6.2 6.5 28.7 12.7 5.6 8.9 6.8 7.6 9.4 4.9 10.3 9.7 3.8 7.8 3.7 5.4 6.0 13.0 22.9 9.5 8.4 13.1 6.2 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favourable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.1 45.2 24.6 15.5 23.4 14.8 30.3 44.3 26.6 35.2 25.1 121.1 40.7 21.7 81.3 20.9 38.2 18.5 26.0 13.5 41.1 52.3 23.3 46.9 95.3 40.0 50.9 23.2 20.4 24.2 27.0 10.2 23.9 45.9 36.6 19.6 62.4 33.2 91.8 27.7 57.1 29.1 46.8 73.3 26.6 54.5 34.8 30.8 31.5 65.0 22.8 51.5 42.3 31.2 34.3 42.3 81.7 37.9 33.7 66.1 49.9 19.5 30.6 32.8 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Approved Supported Mitochondria Mitochondria "CAB070844: , HPA064605: " "prognostic unfavourable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favourable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 13.0 18.8 13.6 17.6 14.3 21.9 19.1 20.7 31.9 23.2 33.5 15.2 14.7 16.9 23.8 18.2 25.1 18.5 28.4 6.7 11.8 29.4 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 24.8 31.7 14.9 20.8 16.2 17.4 14.0 17.5 23.1 17.7 26.3 25.4 26.4 23.8 18.4 14.4 22.0 21.6 31.2 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.7 17.6 18.0 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favourable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 18.0 29.1 18.4 21.3 27.0 24.0 15.9 16.4 24.1 32.4 25.6 31.8 18.8 22.9 30.9 25.2 24.2 29.3 29.3 28.7 15.2 24.7 22.4 21.8 27.8 28.0 24.2 20.8 34.6 25.9 26.2 30.0 37.1 28.6 12.5 30.4 20.8 15.3 12.9 33.5 26.8 13.3 19.0 32.2 38.5 21.6 19.5 29.0 19.8 48.9 27.9 44.0 63.4 23.7 15.8 13.5 11.0 22.1 17.6 27.9 19.2 24.1 20.5 20.3 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004484 Approved Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favourable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 21.9 18.6 19.3 16.1 16.6 15.9 11.0 18.8 27.1 25.8 32.2 20.3 25.6 10.9 15.6 21.3 26.2 19.7 22.1 13.7 42.3 15.5 30.8 31.1 16.5 37.9 20.2 16.2 14.3 10.2 17.0 17.0 22.6 17.8 17.5 35.2 25.9 49.2 26.3 31.0 31.7 26.7 21.1 23.2 18.0 20.8 15.0 14.0 24.1 24.8 26.9 36.3 11.9 16.2 18.2 18.8 24.7 20.4 27.0 28.4 16.5 29.2 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683340 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favourable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 27.5 26.5 29.8 15.7 35.7 14.3 34.0 23.3 35.3 20.8 30.0 12.9 21.3 27.6 24.0 24.2 27.0 22.9 20.9 65.1 24.4 23.2 45.3 48.1 18.7 14.9 28.5 34.4 35.7 19.5 22.2 24.9 20.7 26.7 22.9 30.5 16.4 24.4 26.3 105.5 23.0 25.5 34.3 27.0 13.6 24.1 20.9 24.6 12.9 25.1 67.3 19.3 21.7 22.4 24.3 41.0 6.7 32.8 24.5 25.2 21.9 30.0 26.7 53.2 31.4 36.4 52.8 44.8 36.6 35.8 40.8 50.0 32.5 39.6 21.4 48.3 31.2 22.2 18.8 43.7 47.1 19.8 36.0 14.7 26.6 29.2 38.8 35.4 25.6 43.8 50.6 28.1 49.6 35.4 12.5 23.4 37.2 28.1 26.6 29.7 16.1 30.2 32.1 30.1 42.1 43.4 29.1 24.6 26.6 25.1 24.4 43.0 39.1 37.3 27.0 25.1 26.7 18.2 47.8 18.0 22.4 25.8 26.7 52.0 36.0 6.7 28.9 2.4 17.5 32.8 19.5 24.3 22.2 20.2 41.0 16.5 25.1 25.2 2.4 24.5 32.4 31.0 23.5 21.9 29.8 35.7 23.3 35.3 24.4 23.2 28.5 34.4 26.7 24.6 NDUFS5 CI-15k ENSG00000168653 "NADH:ubiquinone oxidoreductase subunit S5" O43920 1 39026318-39034636 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042582 Supported "HPA042582: " "unprognostic (1.49e-2)" "unprognostic (2.62e-2)" "unprognostic (3.58e-1)" "unprognostic (1.41e-2)" "unprognostic (5.00e-2)" "unprognostic (2.93e-2)" "unprognostic (2.97e-3)" "unprognostic (8.96e-2)" "unprognostic (7.31e-2)" "prognostic favourable (3.54e-4)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.87e-3)" "unprognostic (2.88e-1)" "unprognostic (2.52e-3)" "unprognostic (8.08e-2)" 56.0 62.1 98.7 34.3 84.4 44.5 55.4 48.6 83.7 36.6 62.0 33.7 49.0 42.8 49.4 114.5 59.2 40.9 40.3 166.0 76.3 69.5 61.5 71.3 30.3 35.4 71.6 65.5 49.1 45.8 36.8 46.3 33.0 49.3 44.8 66.9 35.7 72.6 62.9 150.9 36.9 38.2 64.4 46.9 25.1 44.6 22.4 31.9 30.2 47.2 85.8 43.9 55.3 35.1 38.7 64.7 28.4 53.2 36.4 74.4 59.0 43.2 75.5 57.2 69.0 63.0 67.1 75.6 51.8 42.4 51.2 52.1 90.6 58.4 48.6 71.2 55.3 30.3 73.0 70.7 56.9 53.3 85.9 47.8 136.2 150.0 43.8 96.6 36.9 66.9 81.1 54.1 48.6 87.0 76.5 44.3 24.5 96.5 45.9 124.8 99.3 78.3 62.1 81.9 77.3 100.9 140.5 80.0 73.8 60.6 76.7 66.7 51.6 78.2 53.7 41.4 49.0 42.4 86.9 35.7 69.9 68.9 45.5 108.0 55.7 26.1 50.8 28.4 46.1 53.2 52.9 38.7 71.9 53.5 51.7 30.0 74.4 63.5 9.7 36.4 48.9 64.7 66.1 59.0 98.7 84.4 48.6 83.7 76.3 69.5 71.6 65.5 49.3 31.9 NDUFS6 CI-13kA ENSG00000145494 "NADH:ubiquinone oxidoreductase subunit S6" O75380 5 1801400-1816605 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 146.4" "Cell line enhanced" "Detected in all" "HeLa: 102.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064221 Supported 27000 "HPA064221: " "unprognostic (2.34e-1)" "unprognostic (1.43e-3)" "unprognostic (4.04e-1)" "unprognostic (9.74e-2)" "unprognostic (5.91e-2)" "unprognostic (6.27e-2)" "unprognostic (1.13e-2)" "unprognostic (5.67e-2)" "unprognostic (3.22e-1)" "unprognostic (9.99e-3)" "unprognostic (1.68e-3)" "unprognostic (8.57e-2)" "unprognostic (2.14e-2)" "unprognostic (1.16e-3)" "unprognostic (2.46e-1)" "unprognostic (9.08e-2)" "unprognostic (1.02e-1)" 25.0 20.6 19.8 18.9 20.9 23.7 23.9 13.3 26.8 10.6 26.2 11.5 13.6 34.2 13.6 14.4 20.3 10.9 18.8 59.8 17.6 16.5 28.1 43.1 13.5 26.2 19.9 12.9 13.0 29.7 10.5 13.6 17.1 16.1 15.4 12.6 14.7 22.3 19.0 146.4 13.0 27.1 17.8 16.5 16.4 25.4 13.3 9.3 25.5 14.7 36.6 14.1 15.5 12.7 38.7 55.7 35.8 52.8 32.4 40.2 36.7 20.4 28.2 13.8 20.9 5.0 4.5 37.8 17.5 6.2 9.4 8.2 31.0 20.0 28.3 48.3 7.2 20.4 10.3 13.9 5.1 32.0 34.1 21.8 102.7 26.2 10.2 25.6 19.3 6.4 8.9 9.0 6.4 9.1 26.7 21.7 10.1 34.1 36.6 46.9 18.3 39.7 27.3 18.0 33.2 9.7 22.8 17.1 17.2 56.6 36.4 21.8 24.3 30.5 18.4 15.0 34.8 15.4 28.3 26.3 40.2 36.2 18.9 37.4 16.9 31.4 46.5 35.8 35.1 52.8 34.9 38.7 37.2 35.5 55.7 31.0 31.5 35.2 20.2 32.4 45.7 54.5 40.2 36.7 19.8 20.9 13.3 26.8 17.6 16.5 19.9 12.9 16.1 9.3 NDUFS7 "CI-20, FLJ45860, FLJ46880, PSST" ENSG00000115286 "NADH:ubiquinone oxidoreductase core subunit S7" O75251 19 1383527-1395589 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 198.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.36e-2)" "prognostic favourable (2.03e-4)" "unprognostic (5.30e-2)" "unprognostic (3.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (2.41e-2)" "unprognostic (5.85e-2)" "unprognostic (4.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.99e-3)" "unprognostic (8.12e-2)" "prognostic favourable (4.90e-7)" "unprognostic (2.95e-1)" "unprognostic (2.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.34e-2)" 22.4 17.6 15.3 10.1 17.6 9.9 7.0 16.6 22.7 6.1 18.7 20.6 7.6 34.5 7.1 9.6 13.3 6.7 10.0 35.9 16.1 15.1 20.7 20.7 7.1 9.1 19.6 11.9 7.2 28.7 5.0 12.0 6.8 17.6 11.9 4.0 12.0 23.6 10.2 198.0 8.3 25.2 7.5 20.1 11.5 18.2 14.2 14.6 9.7 8.0 39.2 10.0 6.7 7.9 29.1 41.8 19.8 39.1 17.2 29.2 20.8 18.2 18.5 0.6 4.3 0.6 1.7 9.5 11.0 1.1 2.3 2.5 30.3 4.5 27.0 11.3 0.6 9.6 0.8 2.2 0.1 30.1 21.3 8.5 19.8 18.8 2.8 14.7 9.5 1.4 3.8 0.4 0.0 3.2 16.8 10.6 0.6 19.1 14.6 6.1 6.6 22.9 14.2 7.1 27.5 1.1 14.1 10.4 10.6 9.7 9.2 17.9 7.3 9.2 13.8 4.4 6.1 9.6 14.2 42.7 37.2 18.3 11.1 19.9 6.2 19.8 33.6 16.1 21.3 39.1 18.1 29.1 20.1 20.0 41.8 27.1 19.7 19.1 9.1 17.2 31.7 31.6 29.2 20.8 15.3 17.6 16.6 22.7 16.1 15.1 19.6 11.9 17.6 14.6 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018524 Approved Supported Mitochondria "Intracellular and membrane" Mitochondria "HPA018524: AB_1854355" "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favourable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 26.0 62.0 29.9 16.9 40.5 21.0 19.1 18.4 50.1 18.6 24.7 19.7 24.3 34.7 18.2 15.1 28.3 19.0 22.7 82.4 26.5 27.5 50.3 47.6 16.3 19.1 28.3 22.4 20.8 41.3 25.4 26.7 18.0 25.9 22.9 18.3 30.1 41.3 32.2 156.6 17.3 26.7 19.8 18.2 20.3 25.0 21.1 15.7 29.6 29.2 53.9 24.2 19.1 14.8 37.3 66.6 23.6 46.1 59.0 39.6 42.6 26.8 66.7 18.5 25.1 13.8 12.4 24.3 19.1 16.6 29.6 23.0 62.1 28.7 20.8 34.8 16.5 33.2 21.2 23.2 10.6 24.8 48.8 18.9 42.5 32.6 33.0 17.7 20.9 15.6 24.1 21.7 24.9 19.8 19.4 22.6 19.3 63.7 38.9 37.9 22.7 56.6 27.1 17.9 67.3 37.2 21.8 23.2 18.9 13.9 32.2 67.5 44.2 19.4 15.3 28.7 25.3 41.6 26.3 30.9 32.5 17.6 46.2 21.3 20.0 15.8 46.1 23.6 39.6 45.1 37.0 37.3 34.2 36.0 63.3 30.2 33.0 36.7 4.4 59.0 24.9 66.6 39.6 42.6 29.9 40.5 18.4 50.1 26.5 27.5 28.3 22.4 25.9 15.7 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Approved Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: " "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favourable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 26.2 28.2 14.4 28.8 18.0 18.1 26.9 16.4 15.8 25.7 17.2 53.3 31.8 48.5 34.6 14.1 35.4 30.3 25.6 8.1 24.6 23.9 19.9 38.3 26.3 25.5 27.0 22.2 26.8 24.8 20.9 18.7 22.7 36.1 39.7 15.6 39.4 31.5 53.5 14.1 35.5 36.6 27.9 78.7 20.8 19.7 22.9 21.6 20.7 72.5 54.7 36.8 27.5 18.0 24.9 18.6 35.4 17.2 38.8 22.1 24.2 29.0 28.6 23.9 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Mitochondria Mitochondria "HPA003404: AB_1079466, HPA077896: " "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 19.6 20.7 23.9 22.2 17.8 25.3 20.3 24.8 39.5 32.9 31.2 38.6 16.3 30.4 22.8 23.3 10.0 23.2 25.8 31.5 15.3 20.5 19.4 21.3 52.1 20.5 54.0 24.2 21.3 21.6 20.2 22.0 35.4 30.9 96.1 30.1 24.7 37.7 47.4 20.0 25.8 18.0 17.7 115.3 52.4 32.0 25.2 18.7 24.5 28.0 31.2 26.2 41.2 21.6 41.9 29.8 30.0 32.2 27.8 41.2 34.1 29.8 24.0 27.0 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.3 11.0 18.0 13.6 11.8 13.6 19.2 11.0 11.4 9.6 20.7 11.9 10.7 15.2 7.1 10.5 12.8 16.9 7.5 6.1 15.4 35.2 13.3 16.2 21.3 12.0 18.5 13.3 14.7 11.6 18.4 14.4 27.9 13.9 13.1 18.9 8.0 18.2 14.3 22.4 13.8 8.0 33.4 15.4 12.8 8.0 8.4 19.2 22.8 12.7 19.5 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.1 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 PPA1 "IOPPP, PP, PP1, Ppase, SID6-8061" ENSG00000180817 "Pyrophosphatase (inorganic) 1" Q15181 10 70202830-70233911 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019878, HPA020096" Supported Supported Vesicles 110000 Vesicles "HPA019878: AB_1855601, HPA020096: AB_1855600" "unprognostic (1.50e-1)" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" "unprognostic (2.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-1)" "unprognostic (2.13e-2)" "unprognostic (3.60e-2)" "unprognostic (1.82e-3)" "unprognostic (5.36e-2)" "unprognostic (2.37e-1)" "unprognostic (3.53e-2)" "unprognostic (2.74e-1)" 46.6 55.5 41.3 36.8 56.0 24.2 88.7 66.8 62.2 34.8 45.7 25.2 43.7 33.2 30.4 59.6 48.6 38.1 31.5 30.0 46.7 54.2 40.7 59.0 39.1 54.6 74.3 47.5 17.9 72.6 23.3 29.5 34.6 60.7 24.4 53.4 26.1 36.8 42.1 37.0 24.6 41.0 32.8 72.7 22.4 32.5 25.1 47.2 20.4 52.0 35.8 44.4 32.7 40.2 21.5 48.9 1.0 17.7 15.5 35.6 25.3 58.1 24.1 21.6 63.6 58.8 51.9 20.2 21.8 41.0 34.2 36.1 73.4 30.9 84.3 19.9 21.7 47.1 63.2 42.5 35.0 79.2 60.1 23.0 24.4 41.9 37.1 56.6 14.6 34.0 50.9 27.4 73.1 41.3 53.6 45.4 32.2 34.1 54.7 53.2 22.5 66.9 33.5 24.7 49.3 71.3 36.6 64.9 21.8 24.0 94.1 18.6 23.5 25.5 18.7 9.5 36.2 31.2 41.3 15.0 32.8 61.7 14.7 79.5 8.3 0.0 17.7 0.4 13.3 13.8 35.6 21.5 30.8 23.1 48.9 13.8 34.2 28.9 1.0 15.5 14.5 11.3 30.1 25.3 41.3 56.0 66.8 62.2 46.7 54.2 74.3 47.5 60.7 47.2 PPA2 FLJ20459 ENSG00000138777 "Pyrophosphatase (inorganic) 2" Q9H2U2 4 105369077-105474081 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030888, HPA031671, HPA031672" Supported Approved Nucleoplasm,Mitochondria 8300 Mitochondria Nucleoplasm "HPA030888: , HPA031671: AB_10603986, HPA031672: AB_2673988" "prognostic unfavourable (2.98e-4)" "unprognostic (5.64e-2)" "prognostic favourable (6.60e-4)" "unprognostic (9.26e-3)" "unprognostic (2.93e-2)" "unprognostic (5.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.44e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "unprognostic (9.54e-2)" "prognostic favourable (1.27e-11)" "unprognostic (3.69e-1)" "unprognostic (1.94e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" 9.2 18.0 18.4 17.2 15.4 24.0 20.6 12.3 17.6 10.2 19.8 9.3 20.3 18.1 13.3 20.7 14.8 10.7 18.7 42.5 15.6 15.3 23.7 21.2 23.1 34.8 17.2 12.1 9.5 25.0 10.4 15.0 9.3 15.4 16.1 16.7 12.6 21.4 26.8 29.6 15.0 16.8 22.8 12.4 12.1 15.0 9.7 10.7 9.4 14.3 28.2 10.6 12.2 9.5 20.0 35.3 14.7 20.8 22.0 17.0 14.6 11.5 5.5 10.7 18.1 6.8 5.5 7.8 6.5 8.6 8.0 5.7 12.1 17.0 9.5 8.7 5.3 5.8 21.4 10.3 9.5 13.4 7.6 8.5 8.9 11.0 5.4 20.1 8.2 5.3 10.7 5.5 4.3 7.7 14.1 13.1 7.3 14.6 17.1 14.5 7.8 18.7 15.2 6.6 9.3 26.5 8.9 11.0 6.6 4.5 26.7 9.4 14.0 16.4 4.1 5.8 11.3 6.2 11.3 11.6 14.6 9.9 10.1 10.9 7.8 14.7 15.0 9.7 15.3 20.8 13.3 20.0 16.0 16.2 35.3 16.6 15.5 17.0 6.4 22.0 16.2 17.7 15.9 14.6 18.4 15.4 12.3 17.6 15.6 15.3 17.2 12.1 15.4 10.7 PRUNE1 "DRES-17, H-PRUNE, HTCD37, PRUNE" ENSG00000143363 "Prune exopolyphosphatase 1" Q86TP1 1 151008420-151035713 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028411 Uncertain Supported Cytosol 210000 Cytosol "HPA028411: AB_10603229" "unprognostic (6.24e-2)" "unprognostic (2.24e-1)" "unprognostic (4.17e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (6.91e-2)" "unprognostic (2.02e-1)" "unprognostic (2.12e-3)" "unprognostic (7.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.92e-2)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "prognostic unfavourable (3.48e-4)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" 9.3 9.7 9.3 8.8 11.6 3.7 16.0 15.7 16.4 15.0 12.5 10.9 16.2 11.7 17.9 15.7 11.5 15.6 12.8 31.3 10.5 10.3 18.0 12.8 10.1 11.8 11.9 9.2 17.1 16.2 16.5 16.2 7.2 8.8 12.2 14.0 12.7 13.3 18.2 24.4 10.5 11.8 14.7 7.9 11.0 10.5 16.3 8.6 15.0 41.6 8.5 12.9 13.8 13.6 12.1 9.5 14.7 8.9 14.3 19.0 18.3 3.8 4.1 7.4 7.1 9.2 2.5 4.1 1.8 4.0 6.9 6.0 5.1 4.6 7.9 8.0 2.4 5.6 7.2 4.8 5.5 8.6 8.2 9.3 4.3 7.2 5.1 6.1 4.7 3.1 9.2 3.6 3.6 3.2 7.3 6.7 3.2 9.3 9.3 5.0 6.9 5.4 8.5 4.7 7.6 4.9 5.3 10.7 8.7 6.2 8.6 5.7 11.9 9.3 2.2 2.4 2.9 2.7 2.9 16.4 13.8 61.0 2.4 4.7 6.1 12.5 6.4 13.4 14.0 6.0 16.9 12.1 15.5 15.7 9.5 11.6 19.0 15.0 14.7 14.3 8.9 5.1 14.5 18.3 9.3 11.6 15.7 16.4 10.5 10.3 11.9 9.2 8.8 8.6 SDHC "CYB560, cybL, PGL3" ENSG00000143252 "Succinate dehydrogenase complex subunit C" Q99643 1 161314257-161375340 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.48e-2)" "unprognostic (6.88e-2)" "unprognostic (6.38e-3)" "unprognostic (1.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.02e-2)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" "unprognostic (7.38e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "prognostic favourable (2.20e-4)" "unprognostic (9.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.19e-3)" "unprognostic (3.77e-1)" 36.8 49.7 25.6 17.1 27.3 14.1 24.1 14.4 36.2 20.6 29.1 31.2 17.0 34.3 22.1 19.7 35.2 21.4 19.3 35.5 21.5 21.8 65.9 75.3 17.8 20.9 28.6 20.1 20.1 17.2 28.8 17.0 19.2 28.0 20.8 28.4 23.9 28.5 21.9 98.0 21.6 33.4 23.2 24.9 21.2 24.3 17.0 16.2 25.7 35.9 45.4 22.4 20.6 19.2 31.3 60.4 28.3 48.2 29.0 38.6 47.9 30.0 22.0 31.0 26.7 40.9 32.8 34.3 33.3 26.6 25.9 20.0 32.5 37.4 8.9 43.4 33.6 35.2 41.4 35.0 30.0 31.9 40.6 20.6 21.0 33.4 23.3 38.2 22.2 34.5 28.9 30.1 20.3 26.9 29.0 8.4 41.7 28.9 27.1 22.1 30.5 23.3 28.5 30.3 37.9 54.6 29.9 21.7 36.9 40.1 75.6 47.7 61.7 48.0 23.7 18.0 27.6 25.4 28.8 44.0 53.7 52.9 26.3 25.0 34.8 27.7 48.2 28.3 36.0 44.9 38.6 31.3 32.3 35.5 60.4 30.6 36.3 35.7 23.9 29.0 38.8 44.8 35.2 47.9 25.6 27.3 14.4 36.2 21.5 21.8 28.6 20.1 28.0 16.2 UQCR10 "HSPC051, QCR9, UCCR7.2, UCRC" ENSG00000184076 "Ubiquinol-cytochrome c reductase, complex III subunit X" Q9UDW1 22 29767369-29770413 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 144.4;skeletal muscle: 144.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.09e-1)" "unprognostic (2.96e-3)" "unprognostic (1.56e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (2.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.75e-3)" "unprognostic (3.05e-2)" "unprognostic (9.24e-3)" "unprognostic (2.94e-1)" "unprognostic (1.12e-2)" "prognostic favourable (5.45e-5)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.80e-3)" 23.0 37.0 42.5 18.2 42.9 20.1 23.8 25.2 48.5 17.2 35.5 14.7 24.3 35.9 12.6 24.9 23.7 23.7 19.9 97.9 38.3 30.2 38.3 43.6 22.6 25.2 39.8 25.8 16.1 39.4 19.3 22.5 17.5 25.4 22.2 29.1 21.6 25.2 25.6 144.7 14.7 33.1 17.6 24.2 19.8 29.9 28.5 20.6 20.9 23.6 62.9 20.8 22.8 15.0 132.9 126.0 141.5 118.4 73.9 123.2 144.4 31.3 33.0 31.8 24.7 29.9 19.7 17.7 17.5 21.9 31.3 32.9 42.5 18.1 23.7 19.1 27.6 31.4 37.7 40.9 19.6 29.5 79.3 29.6 40.0 92.9 21.4 38.0 32.4 33.0 25.1 32.6 22.1 23.2 20.1 32.1 30.7 79.2 28.5 44.7 18.2 43.7 31.1 25.5 43.0 53.9 60.0 35.2 17.7 20.3 43.7 27.4 31.0 36.5 18.2 32.4 39.2 19.8 25.7 24.2 24.5 31.6 29.2 29.5 20.3 112.9 118.4 141.5 71.0 115.5 77.6 132.9 98.0 90.9 123.1 107.0 106.8 91.6 82.2 73.9 102.8 126.0 123.2 144.4 42.5 42.9 25.2 48.5 38.3 30.2 39.8 25.8 25.4 20.6 UQCR11 "QCR10, UQCR" ENSG00000127540 "Ubiquinol-cytochrome c reductase, complex III subunit XI" O14957 19 1597172-1605490 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.4;skeletal muscle: 149.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "unprognostic (1.90e-1)" "unprognostic (6.67e-3)" "unprognostic (1.78e-1)" "prognostic favourable (1.23e-4)" "unprognostic (5.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (5.42e-3)" "unprognostic (9.10e-2)" "unprognostic (1.14e-1)" "prognostic favourable (1.86e-4)" "unprognostic (1.03e-1)" "prognostic favourable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (1.06e-2)" 24.9 23.6 35.1 15.8 29.5 20.3 18.5 13.2 25.1 12.5 28.5 13.1 20.3 34.4 12.4 18.2 22.9 14.1 21.7 106.4 26.9 21.1 24.4 46.1 11.9 17.2 31.0 19.2 9.8 30.0 8.8 16.7 15.4 18.5 18.3 13.3 14.5 29.6 23.6 149.2 11.5 27.5 16.8 21.5 18.3 27.6 8.8 15.1 10.9 22.0 47.1 12.9 15.8 14.1 63.8 78.6 88.2 75.6 43.8 67.9 125.4 22.5 21.2 10.5 23.8 17.5 12.0 25.5 16.3 12.8 16.1 14.4 34.2 15.2 13.3 16.9 11.5 14.4 15.4 17.3 7.5 21.8 47.1 11.7 26.2 32.1 18.2 19.3 18.3 18.5 17.9 10.1 11.8 14.5 25.8 24.2 10.1 31.0 19.2 23.4 27.4 51.1 11.7 11.0 44.5 20.9 45.6 20.9 22.3 11.2 27.1 28.7 19.2 23.1 20.2 15.6 10.2 41.1 18.9 34.2 28.1 16.4 27.4 20.2 21.1 83.7 75.6 87.0 52.6 61.8 52.9 63.8 64.3 58.2 63.1 54.1 61.7 59.3 88.2 43.8 57.4 78.6 67.9 125.4 35.1 29.5 13.2 25.1 26.9 21.1 31.0 19.2 18.5 15.1 UQCRB "QCR7, QP-C, UQBP, UQCR6" ENSG00000156467 "Ubiquinol-cytochrome c reductase binding protein" P14927 8 96225920-96235634 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 234.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA043060 Approved 380000 "HPA043060: AB_10806376" "unprognostic (5.48e-2)" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (9.47e-3)" "unprognostic (2.15e-1)" "unprognostic (8.41e-2)" "unprognostic (2.79e-1)" "unprognostic (9.20e-2)" "unprognostic (3.98e-1)" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.92e-1)" "prognostic favourable (2.90e-4)" "unprognostic (1.01e-1)" "unprognostic (7.54e-2)" "unprognostic (1.07e-1)" "unprognostic (5.66e-3)" 37.8 51.7 52.1 27.8 54.3 31.3 27.9 25.5 44.0 31.1 37.7 17.9 28.5 35.2 30.7 41.3 38.6 25.5 27.9 156.1 42.3 39.6 57.3 45.1 22.0 28.1 52.2 35.6 48.7 35.2 25.5 45.5 20.3 41.9 35.6 33.8 19.4 42.0 31.7 234.1 16.8 31.7 57.8 44.3 26.9 30.6 15.5 30.8 22.9 33.0 90.0 31.9 51.2 33.8 50.3 38.5 31.9 65.4 30.3 64.4 46.4 57.3 27.5 35.7 22.7 51.7 52.9 23.3 46.4 35.5 25.8 27.7 24.9 27.7 25.1 70.6 37.2 28.2 32.5 43.3 34.6 37.7 25.9 82.4 52.9 41.3 38.0 45.6 35.2 61.7 38.8 29.0 46.4 37.4 43.3 43.6 39.5 37.2 72.4 69.9 21.0 42.4 32.6 23.6 46.2 50.4 46.1 32.8 32.8 28.1 10.8 70.4 44.4 76.5 45.3 17.0 25.8 29.7 49.5 37.7 28.3 58.0 27.8 61.6 18.4 26.6 34.8 31.9 32.2 56.4 39.5 50.3 52.0 40.2 38.5 38.7 64.4 58.8 24.7 30.3 65.4 33.7 56.8 46.4 52.1 54.3 25.5 44.0 42.3 39.6 52.2 35.6 41.9 30.8 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell line enhanced" "Detected in all" "PC-3: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria,Cytosol 1300000 Mitochondria Cytosol "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favourable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.0 16.2 5.9 3.6 8.7 8.0 26.7 18.5 15.0 15.4 14.0 25.2 3.0 25.9 11.7 8.3 9.7 7.4 21.5 2.8 15.4 35.5 26.6 14.1 27.4 17.3 16.7 11.5 11.0 24.4 10.5 17.2 15.2 14.3 1.7 9.3 17.4 12.0 19.1 14.8 64.6 8.2 15.7 21.2 15.9 11.0 6.3 11.2 25.1 3.0 14.8 6.4 2.6 15.3 4.3 16.3 13.4 19.1 15.8 13.9 15.0 9.4 19.3 13.7 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21952660-21983660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria 4000000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favourable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 22.7 26.8 20.6 17.1 32.7 20.5 21.3 29.2 33.7 17.7 38.4 17.4 19.5 45.0 20.8 18.6 28.7 20.0 19.1 94.9 19.8 19.3 35.1 35.8 15.9 23.6 20.9 28.5 21.9 20.8 36.6 20.2 17.8 29.6 17.7 40.5 18.5 22.1 20.2 103.9 22.2 42.0 30.4 16.5 16.5 29.3 10.3 19.2 25.2 21.4 70.0 22.9 27.9 20.0 20.0 30.6 14.3 29.3 18.7 25.7 27.4 18.9 20.9 12.9 8.6 14.4 20.2 18.3 18.4 15.0 16.9 17.2 33.7 18.8 37.7 16.6 15.8 34.7 20.9 18.5 19.5 17.2 19.4 21.3 18.4 47.6 15.3 27.1 54.0 23.6 23.2 13.2 18.2 22.1 23.0 19.7 18.3 25.2 28.1 17.6 14.1 16.1 32.9 29.9 41.2 25.3 22.4 17.8 13.0 26.1 33.0 19.8 37.8 28.8 19.5 12.0 11.3 11.7 16.4 14.3 10.3 33.4 19.6 28.8 13.7 14.3 24.7 12.8 16.9 29.3 21.9 20.0 20.5 18.6 30.6 15.8 22.8 20.8 9.1 18.7 27.6 13.2 25.7 27.4 20.6 32.7 29.2 33.7 19.8 19.3 20.9 28.5 29.6 19.2 UQCRFS1 "RIP1, RIS1, RISP, UQCR5" ENSG00000169021 "Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1" P47985 19 29205321-29213541 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041863, HPA050339" Enhanced Approved Mitochondria Mitochondria "HPA041863: AB_10794638, HPA050339: AB_2681095" "unprognostic (4.00e-2)" "unprognostic (2.23e-3)" "prognostic favourable (3.29e-4)" "unprognostic (7.91e-3)" "unprognostic (3.93e-2)" "unprognostic (8.68e-2)" "unprognostic (1.84e-1)" "unprognostic (7.53e-2)" "unprognostic (3.53e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "prognostic favourable (3.92e-9)" "unprognostic (6.11e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (1.92e-2)" 15.2 27.1 20.1 10.8 18.3 25.4 28.2 18.3 33.4 11.9 27.3 9.1 9.8 24.3 10.5 14.3 16.9 11.9 14.2 95.3 19.4 14.8 34.9 33.8 12.0 21.2 18.3 13.1 9.1 26.4 15.9 10.6 10.8 17.6 11.8 30.3 11.5 17.0 13.9 112.3 12.9 27.0 19.6 11.5 11.3 18.8 16.6 6.5 17.7 12.9 55.0 14.5 13.7 10.0 18.5 35.6 14.9 29.9 15.0 22.1 45.1 23.0 38.9 14.5 13.0 23.8 18.2 16.1 18.0 18.9 25.0 27.7 23.5 14.3 21.0 19.0 20.3 24.5 31.6 21.4 30.2 14.2 31.7 29.7 15.4 21.4 20.2 28.2 26.1 21.8 23.2 17.0 26.0 19.9 21.0 13.2 26.7 21.3 19.7 21.1 15.1 15.1 18.0 19.3 15.9 31.0 27.8 17.6 8.6 16.4 32.6 20.6 15.1 23.5 12.5 16.9 25.8 11.6 18.6 6.3 11.9 19.3 14.9 24.6 12.0 14.9 29.9 14.0 17.9 29.3 17.8 18.5 19.2 18.3 35.6 15.7 20.4 19.4 9.1 15.0 24.3 19.7 22.1 45.1 20.1 18.3 18.3 33.4 19.4 14.8 18.3 13.1 17.6 6.5 UQCRH "QCR6, UQCR8" ENSG00000173660 "Ubiquinol-cytochrome c reductase hinge protein" P07919 1 46303631-46316776 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042574 Supported "HPA042574: AB_10960998" "unprognostic (2.24e-2)" "unprognostic (6.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.06e-3)" "unprognostic (6.34e-2)" "unprognostic (6.58e-2)" "prognostic unfavourable (4.63e-5)" "unprognostic (1.31e-1)" "unprognostic (3.15e-2)" "unprognostic (2.56e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-3)" "unprognostic (2.07e-2)" "unprognostic (3.77e-1)" "unprognostic (5.14e-2)" "unprognostic (1.04e-1)" 31.3 25.8 57.4 29.5 56.6 52.2 36.7 59.1 73.9 28.4 63.4 11.6 37.1 61.3 23.6 32.8 48.5 18.3 28.9 140.9 48.8 48.6 52.5 38.8 22.2 37.0 55.9 57.0 36.5 66.4 33.4 25.3 21.2 52.9 23.1 64.2 18.9 60.5 40.4 132.5 26.3 44.2 38.4 42.7 24.6 37.3 14.0 26.7 23.9 20.5 76.0 49.4 29.6 30.1 82.4 72.4 35.8 56.4 30.5 57.7 82.4 48.2 28.3 33.7 60.2 34.5 46.9 70.0 32.1 19.1 27.6 23.8 54.5 26.7 47.4 42.7 29.7 34.7 46.7 49.0 41.2 35.5 80.4 117.8 81.6 72.8 20.3 115.9 33.8 53.1 28.0 45.8 23.1 38.8 110.9 52.9 42.0 37.2 52.1 118.3 201.3 57.8 54.9 55.3 147.6 60.5 103.1 65.5 77.9 52.5 98.9 98.6 32.8 143.4 34.8 27.0 35.4 38.7 59.6 36.3 71.9 74.8 39.1 90.2 40.3 20.4 56.4 35.8 35.2 47.9 45.1 82.4 50.8 46.2 72.4 61.5 57.7 51.5 10.7 30.5 40.8 49.6 50.5 82.4 57.4 56.6 59.1 73.9 48.8 48.6 55.9 57.0 52.9 26.7 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria Mitochondria "HPA046693: AB_10968453, HPA053323: " "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favourable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.6 63.9 37.7 91.2 56.6 46.0 32.7 33.1 46.9 53.1 66.3 89.9 53.4 18.8 70.1 43.4 46.3 34.3 80.8 45.7 34.3 72.2 24.9 100.7 70.6 49.1 28.2 42.9 49.0 56.4 37.9 52.3 41.4 31.8 60.6 55.6 86.5 64.8 65.1 26.7 57.7 42.5 41.8 80.7 68.7 89.2 63.3 52.7 41.0 46.3 70.8 69.0 65.0 25.7 48.7 61.5 39.9 67.0 67.0 88.9 33.6 64.8 52.6 48.4 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8